{"transactions":[{"id":1671322,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"other":true,"other_text":"See remarks"}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"other":true,"other_text":"See remarks"}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"other":true,"other_text":"See remarks"}},{"id":94909,"kind":"person","name":"Dissanayake Shehan Bharatha","position":6,"cik":"0001663609","reported_name":"Dissanayake Shehan Bharatha","relationship":{"other":true,"other_text":"See remarks"}},{"id":94910,"kind":"person","name":"Fuglesang Christopher","position":7,"cik":"0001465835","reported_name":"Fuglesang Christopher","relationship":{"other":true,"other_text":"See remarks"}},{"id":94911,"kind":"organization","name":"Braslyn Ltd.","position":8,"cik":"0001642355","reported_name":"Braslyn Ltd.","relationship":{"other":true,"other_text":"See remarks"}},{"id":94912,"kind":"organization","name":"Lockend Five, LLC","position":9,"cik":"0001830602","reported_name":"Lockend Five, LLC","relationship":{"other":true,"other_text":"See remarks"}}],"security":"Warrant (right to purchase)","published_at":"2024-01-25T16:32:24.000Z","date":"2024-01-23","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1413475,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F7","text":"By virtue of the Merger, each then unexpired and unexercised issued and outstanding warrant to purchase shares of Common Stock issued by or on behalf of the Company (each, a \"Company Warrant\") that was outstanding as of immediately prior to the Effective Time was converted into the right to receive, upon exercise of such Company Warrant, the same Merger Consideration as the holder would have been entitled to receive following the Effective Time if such holder had been, immediately prior to the Effective Time, the holder of the number of shares of Company common stock then issuable upon exercise in full of such Company Warrant without regard to any limitations on exercise contained therein."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"By virtue of the Merger, each then unexpired and unexercised issued and outstanding warrant to purchase shares of Common Stock issued by or on behalf of the Company (each, a \"Company Warrant\") that was outstanding as of immediately prior to the Effective Time was converted into the right to receive, upon exercise of such Company Warrant, the same Merger Consideration as the holder would have been entitled to receive following the Effective Time if such holder had been, immediately prior to the Effective Time, the holder of the number of shares of Company common stock then issuable upon exercise in full of such Company Warrant without regard to any limitations on exercise contained therein."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"These Company Warrants do not have an expiration date and are not exercisable to the extent that, following exercise, the holder of such Company Warrant and its affiliates would beneficially own more than 19.99% of the Common Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"These securities are owned directly by Braslyn Ltd., which is owned by a revocable trust established by Mr. Lewis for the benefit of members of his immediate family. Each reporting person other than Braslyn Ltd. and Mr. Lewis disclaims beneficial ownership of these securities."}],"balance_after":0,"derivative":{"exercise_price":0.001,"exercise_date":"2017-11-20","underlying":"Common Stock","underlying_shares":1413475},"source":{"system":"sec-edgar","filing":"0000895345-24-000019","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089534524000019/form4.xml","form_type":"4"}},{"id":1671321,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"other":true,"other_text":"See remarks"}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"other":true,"other_text":"See remarks"}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"other":true,"other_text":"See remarks"}},{"id":94909,"kind":"person","name":"Dissanayake Shehan Bharatha","position":6,"cik":"0001663609","reported_name":"Dissanayake Shehan Bharatha","relationship":{"other":true,"other_text":"See remarks"}},{"id":94910,"kind":"person","name":"Fuglesang Christopher","position":7,"cik":"0001465835","reported_name":"Fuglesang Christopher","relationship":{"other":true,"other_text":"See remarks"}},{"id":94911,"kind":"organization","name":"Braslyn Ltd.","position":8,"cik":"0001642355","reported_name":"Braslyn Ltd.","relationship":{"other":true,"other_text":"See remarks"}},{"id":94912,"kind":"organization","name":"Lockend Five, LLC","position":9,"cik":"0001830602","reported_name":"Lockend Five, LLC","relationship":{"other":true,"other_text":"See remarks"}}],"security":"Warrant (right to purchase)","published_at":"2024-01-25T16:32:24.000Z","date":"2024-01-23","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":3578036,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F7","text":"By virtue of the Merger, each then unexpired and unexercised issued and outstanding warrant to purchase shares of Common Stock issued by or on behalf of the Company (each, a \"Company Warrant\") that was outstanding as of immediately prior to the Effective Time was converted into the right to receive, upon exercise of such Company Warrant, the same Merger Consideration as the holder would have been entitled to receive following the Effective Time if such holder had been, immediately prior to the Effective Time, the holder of the number of shares of Company common stock then issuable upon exercise in full of such Company Warrant without regard to any limitations on exercise contained therein."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"By virtue of the Merger, each then unexpired and unexercised issued and outstanding warrant to purchase shares of Common Stock issued by or on behalf of the Company (each, a \"Company Warrant\") that was outstanding as of immediately prior to the Effective Time was converted into the right to receive, upon exercise of such Company Warrant, the same Merger Consideration as the holder would have been entitled to receive following the Effective Time if such holder had been, immediately prior to the Effective Time, the holder of the number of shares of Company common stock then issuable upon exercise in full of such Company Warrant without regard to any limitations on exercise contained therein."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"These Company Warrants do not have an expiration date and are not exercisable to the extent that, following exercise, the holder of such Company Warrant and its affiliates would beneficially own more than 19.99% of the Common Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"These securities are owned directly by Braslyn Ltd., which is owned by a revocable trust established by Mr. Lewis for the benefit of members of his immediate family. Each reporting person other than Braslyn Ltd. and Mr. Lewis disclaims beneficial ownership of these securities."}],"balance_after":0,"derivative":{"exercise_price":0.001,"exercise_date":"2017-01-06","underlying":"Common Stock","underlying_shares":3578036},"source":{"system":"sec-edgar","filing":"0000895345-24-000019","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089534524000019/form4.xml","form_type":"4"}},{"id":1671320,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"other":true,"other_text":"See remarks"}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"other":true,"other_text":"See remarks"}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"other":true,"other_text":"See remarks"}},{"id":94909,"kind":"person","name":"Dissanayake Shehan Bharatha","position":6,"cik":"0001663609","reported_name":"Dissanayake Shehan Bharatha","relationship":{"other":true,"other_text":"See remarks"}},{"id":94910,"kind":"person","name":"Fuglesang Christopher","position":7,"cik":"0001465835","reported_name":"Fuglesang Christopher","relationship":{"other":true,"other_text":"See remarks"}},{"id":94911,"kind":"organization","name":"Braslyn Ltd.","position":8,"cik":"0001642355","reported_name":"Braslyn Ltd.","relationship":{"other":true,"other_text":"See remarks"}},{"id":94912,"kind":"organization","name":"Lockend Five, LLC","position":9,"cik":"0001830602","reported_name":"Lockend Five, LLC","relationship":{"other":true,"other_text":"See remarks"}}],"security":"Warrant (right to purchase)","published_at":"2024-01-25T16:32:24.000Z","date":"2024-01-23","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":332809,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F7","text":"By virtue of the Merger, each then unexpired and unexercised issued and outstanding warrant to purchase shares of Common Stock issued by or on behalf of the Company (each, a \"Company Warrant\") that was outstanding as of immediately prior to the Effective Time was converted into the right to receive, upon exercise of such Company Warrant, the same Merger Consideration as the holder would have been entitled to receive following the Effective Time if such holder had been, immediately prior to the Effective Time, the holder of the number of shares of Company common stock then issuable upon exercise in full of such Company Warrant without regard to any limitations on exercise contained therein."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"By virtue of the Merger, each then unexpired and unexercised issued and outstanding warrant to purchase shares of Common Stock issued by or on behalf of the Company (each, a \"Company Warrant\") that was outstanding as of immediately prior to the Effective Time was converted into the right to receive, upon exercise of such Company Warrant, the same Merger Consideration as the holder would have been entitled to receive following the Effective Time if such holder had been, immediately prior to the Effective Time, the holder of the number of shares of Company common stock then issuable upon exercise in full of such Company Warrant without regard to any limitations on exercise contained therein."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"These Company Warrants do not have an expiration date and are not exercisable to the extent that, following exercise, the holder of such Company Warrant and its affiliates would beneficially own more than 19.99% of the Common Stock."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"These securities are owned directly by Boxer Capital, LLC (\"Boxer Capital\"). Boxer Asset Management Inc. (\"Boxer Management\") is the managing member of Boxer Capital. Joseph Lewis is the sole indirect owner of Boxer Management. Each of Messrs. Fuglesang, Dissanayake and Davis is a member of Boxer Capital. Each reporting person other than Boxer Capital disclaims beneficial ownership of these securities except to the extent of such person's pecuniary interest therein, if any."}],"balance_after":0,"derivative":{"exercise_price":0.001,"exercise_date":"2017-11-20","underlying":"Common Stock","underlying_shares":332809},"source":{"system":"sec-edgar","filing":"0000895345-24-000019","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089534524000019/form4.xml","form_type":"4"}},{"id":1671319,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"other":true,"other_text":"See remarks"}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"other":true,"other_text":"See remarks"}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"other":true,"other_text":"See remarks"}},{"id":94909,"kind":"person","name":"Dissanayake Shehan Bharatha","position":6,"cik":"0001663609","reported_name":"Dissanayake Shehan Bharatha","relationship":{"other":true,"other_text":"See remarks"}},{"id":94910,"kind":"person","name":"Fuglesang Christopher","position":7,"cik":"0001465835","reported_name":"Fuglesang Christopher","relationship":{"other":true,"other_text":"See remarks"}},{"id":94911,"kind":"organization","name":"Braslyn Ltd.","position":8,"cik":"0001642355","reported_name":"Braslyn Ltd.","relationship":{"other":true,"other_text":"See remarks"}},{"id":94912,"kind":"organization","name":"Lockend Five, LLC","position":9,"cik":"0001830602","reported_name":"Lockend Five, LLC","relationship":{"other":true,"other_text":"See remarks"}}],"security":"Common Stock","published_at":"2024-01-25T16:32:24.000Z","date":"2024-01-23","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":30518,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On January 23, 2024, Mirati Therapeutics, Inc. (the \"Company\") filed a Form 8-K with the SEC announcing the consummation of a transaction in which the Company became a wholly owned subsidiary of Bristol-Myers Squibb Company, as described in greater detail therein (the \"Merger\"). As described in that 8-K, upon the effective time (the \"Effective Time\") of the Merger each share of Company common stock, par value $0.001 per share, of the Company (\"Common Stock\") (with certain exceptions) was automatically converted into the right to receive (i) cash in an amount equal to $58.00 subject to applicable withholding tax and (ii) one contingent value right (a \"CVR\") representing the right to receive $12.00 in cash, without interest and subject to any applicable tax withholding upon achievement of a specified milestone is achieved (as further explained in the Form 8-K) (the consideration contemplated by (i) and (ii), together, the \"Merger Consideration\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"These securities are owned directly by Mr. Fuglesang. Each reporting person other than Mr. Fuglesang disclaims beneficial ownership of these securities."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000895345-24-000019","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089534524000019/form4.xml","form_type":"4"}},{"id":1671318,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"other":true,"other_text":"See remarks"}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"other":true,"other_text":"See remarks"}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"other":true,"other_text":"See remarks"}},{"id":94909,"kind":"person","name":"Dissanayake Shehan Bharatha","position":6,"cik":"0001663609","reported_name":"Dissanayake Shehan Bharatha","relationship":{"other":true,"other_text":"See remarks"}},{"id":94910,"kind":"person","name":"Fuglesang Christopher","position":7,"cik":"0001465835","reported_name":"Fuglesang Christopher","relationship":{"other":true,"other_text":"See remarks"}},{"id":94911,"kind":"organization","name":"Braslyn Ltd.","position":8,"cik":"0001642355","reported_name":"Braslyn Ltd.","relationship":{"other":true,"other_text":"See remarks"}},{"id":94912,"kind":"organization","name":"Lockend Five, LLC","position":9,"cik":"0001830602","reported_name":"Lockend Five, LLC","relationship":{"other":true,"other_text":"See remarks"}}],"security":"Common Stock","published_at":"2024-01-25T16:32:24.000Z","date":"2024-01-23","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":3135966,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On January 23, 2024, Mirati Therapeutics, Inc. (the \"Company\") filed a Form 8-K with the SEC announcing the consummation of a transaction in which the Company became a wholly owned subsidiary of Bristol-Myers Squibb Company, as described in greater detail therein (the \"Merger\"). As described in that 8-K, upon the effective time (the \"Effective Time\") of the Merger each share of Company common stock, par value $0.001 per share, of the Company (\"Common Stock\") (with certain exceptions) was automatically converted into the right to receive (i) cash in an amount equal to $58.00 subject to applicable withholding tax and (ii) one contingent value right (a \"CVR\") representing the right to receive $12.00 in cash, without interest and subject to any applicable tax withholding upon achievement of a specified milestone is achieved (as further explained in the Form 8-K) (the consideration contemplated by (i) and (ii), together, the \"Merger Consideration\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"These securities are owned directly by Braslyn Ltd., which is owned by a revocable trust established by Mr. Lewis for the benefit of members of his immediate family. Each reporting person other than Braslyn Ltd. and Mr. Lewis disclaims beneficial ownership of these securities."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000895345-24-000019","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089534524000019/form4.xml","form_type":"4"}},{"id":1671317,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"other":true,"other_text":"See remarks"}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"other":true,"other_text":"See remarks"}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"other":true,"other_text":"See remarks"}},{"id":94909,"kind":"person","name":"Dissanayake Shehan Bharatha","position":6,"cik":"0001663609","reported_name":"Dissanayake Shehan Bharatha","relationship":{"other":true,"other_text":"See remarks"}},{"id":94910,"kind":"person","name":"Fuglesang Christopher","position":7,"cik":"0001465835","reported_name":"Fuglesang Christopher","relationship":{"other":true,"other_text":"See remarks"}},{"id":94911,"kind":"organization","name":"Braslyn Ltd.","position":8,"cik":"0001642355","reported_name":"Braslyn Ltd.","relationship":{"other":true,"other_text":"See remarks"}},{"id":94912,"kind":"organization","name":"Lockend Five, LLC","position":9,"cik":"0001830602","reported_name":"Lockend Five, LLC","relationship":{"other":true,"other_text":"See remarks"}}],"security":"Common Stock","published_at":"2024-01-25T16:32:24.000Z","date":"2024-01-23","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":203754,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On January 23, 2024, Mirati Therapeutics, Inc. (the \"Company\") filed a Form 8-K with the SEC announcing the consummation of a transaction in which the Company became a wholly owned subsidiary of Bristol-Myers Squibb Company, as described in greater detail therein (the \"Merger\"). As described in that 8-K, upon the effective time (the \"Effective Time\") of the Merger each share of Company common stock, par value $0.001 per share, of the Company (\"Common Stock\") (with certain exceptions) was automatically converted into the right to receive (i) cash in an amount equal to $58.00 subject to applicable withholding tax and (ii) one contingent value right (a \"CVR\") representing the right to receive $12.00 in cash, without interest and subject to any applicable tax withholding upon achievement of a specified milestone is achieved (as further explained in the Form 8-K) (the consideration contemplated by (i) and (ii), together, the \"Merger Consideration\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"These securities are owned directly by Lockend Five, LLC, a limited liability company owned soley by Mr. Dissanayake.  Each reporting person other than Lockend Five, LLC and Mr. Dissanayake disclaims beneficial ownership of these securities."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000895345-24-000019","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089534524000019/form4.xml","form_type":"4"}},{"id":1671316,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"other":true,"other_text":"See remarks"}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"other":true,"other_text":"See remarks"}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"other":true,"other_text":"See remarks"}},{"id":94909,"kind":"person","name":"Dissanayake Shehan Bharatha","position":6,"cik":"0001663609","reported_name":"Dissanayake Shehan Bharatha","relationship":{"other":true,"other_text":"See remarks"}},{"id":94910,"kind":"person","name":"Fuglesang Christopher","position":7,"cik":"0001465835","reported_name":"Fuglesang Christopher","relationship":{"other":true,"other_text":"See remarks"}},{"id":94911,"kind":"organization","name":"Braslyn Ltd.","position":8,"cik":"0001642355","reported_name":"Braslyn Ltd.","relationship":{"other":true,"other_text":"See remarks"}},{"id":94912,"kind":"organization","name":"Lockend Five, LLC","position":9,"cik":"0001830602","reported_name":"Lockend Five, LLC","relationship":{"other":true,"other_text":"See remarks"}}],"security":"Common Stock","published_at":"2024-01-25T16:32:24.000Z","date":"2024-01-23","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":3201440,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On January 23, 2024, Mirati Therapeutics, Inc. (the \"Company\") filed a Form 8-K with the SEC announcing the consummation of a transaction in which the Company became a wholly owned subsidiary of Bristol-Myers Squibb Company, as described in greater detail therein (the \"Merger\"). As described in that 8-K, upon the effective time (the \"Effective Time\") of the Merger each share of Company common stock, par value $0.001 per share, of the Company (\"Common Stock\") (with certain exceptions) was automatically converted into the right to receive (i) cash in an amount equal to $58.00 subject to applicable withholding tax and (ii) one contingent value right (a \"CVR\") representing the right to receive $12.00 in cash, without interest and subject to any applicable tax withholding upon achievement of a specified milestone is achieved (as further explained in the Form 8-K) (the consideration contemplated by (i) and (ii), together, the \"Merger Consideration\")."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"These securities are owned directly by Boxer Capital, LLC (\"Boxer Capital\"). Boxer Asset Management Inc. (\"Boxer Management\") is the managing member of Boxer Capital. Joseph Lewis is the sole indirect owner of Boxer Management. Each of Messrs. Fuglesang, Dissanayake and Davis is a member of Boxer Capital. Each reporting person other than Boxer Capital disclaims beneficial ownership of these securities except to the extent of such person's pecuniary interest therein, if any."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000895345-24-000019","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089534524000019/form4.xml","form_type":"4"}},{"id":1671315,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"other":true,"other_text":"See remarks"}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"other":true,"other_text":"See remarks"}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":4,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"other":true,"other_text":"See remarks"}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"other":true,"other_text":"See remarks"}},{"id":94909,"kind":"person","name":"Dissanayake Shehan Bharatha","position":6,"cik":"0001663609","reported_name":"Dissanayake Shehan Bharatha","relationship":{"other":true,"other_text":"See remarks"}},{"id":94910,"kind":"person","name":"Fuglesang Christopher","position":7,"cik":"0001465835","reported_name":"Fuglesang Christopher","relationship":{"other":true,"other_text":"See remarks"}},{"id":94911,"kind":"organization","name":"Braslyn Ltd.","position":8,"cik":"0001642355","reported_name":"Braslyn Ltd.","relationship":{"other":true,"other_text":"See remarks"}},{"id":94912,"kind":"organization","name":"Lockend Five, LLC","position":9,"cik":"0001830602","reported_name":"Lockend Five, LLC","relationship":{"other":true,"other_text":"See remarks"}}],"security":"Common Stock","published_at":"2024-01-25T16:32:24.000Z","date":"2024-01-23","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":287866,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On January 23, 2024, Mirati Therapeutics, Inc. (the \"Company\") filed a Form 8-K with the SEC announcing the consummation of a transaction in which the Company became a wholly owned subsidiary of Bristol-Myers Squibb Company, as described in greater detail therein (the \"Merger\"). As described in that 8-K, upon the effective time (the \"Effective Time\") of the Merger each share of Company common stock, par value $0.001 per share, of the Company (\"Common Stock\") (with certain exceptions) was automatically converted into the right to receive (i) cash in an amount equal to $58.00 subject to applicable withholding tax and (ii) one contingent value right (a \"CVR\") representing the right to receive $12.00 in cash, without interest and subject to any applicable tax withholding upon achievement of a specified milestone is achieved (as further explained in the Form 8-K) (the consideration contemplated by (i) and (ii), together, the \"Merger Consideration\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are owned directly by MVA Investors, LLC (\"MVA Investors\"). Aaron I. Davis is a member of and has voting and dispositive power over securities held by MVA Investors. Each reporting person other than MVA Investors disclaims beneficial ownership of these securities except to the extent of such person's pecuniary interest therein, if any."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000895345-24-000019","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089534524000019/form4.xml","form_type":"4"}},{"id":2797808,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":94911,"kind":"organization","name":"Braslyn Ltd.","position":1,"cik":"0001642355","reported_name":"Braslyn Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":2,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (right to purchase)","published_at":"2021-03-10T21:30:11.000Z","date":"2020-03-10","kind":"exercise","acquired":false,"shares":410,"price":5.599,"value":2295.59,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The warrants do not have an expiration date and are not exercisable to the extent that, following exercise of such warrants, the warrant holder and its affiliates would beneficially own more than 19.99% of the issuer's common stock."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Tese securities are owned directly by Braslyn Ltd (\"Braslyn\"), which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Braslyn, (ii) Boxer Capital, LLC, (iii) Boxer Asset Management Inc., (iv) MVA Investors, LLC, (v) Lockend Five, LLC, (vi) Joe Lewis, (vii) Ivan M. Lieberburg, (viii) Aaron I. Davis, (ix) Shehan B. Dissanayake, and (x) Christopher Fuglesang (collectively, the \"Boxer Group). Each of Messrs. Fuglesang, Lieberburg, Dissanayake and Davis is a member of Boxer Capital. Each member of the Boxer Group other than Braslyn disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein."}],"balance_after":3578040,"derivative":{"exercise_price":0.001,"exercise_date":"2017-01-06","underlying":"Common Stock","underlying_shares":410},"source":{"system":"sec-edgar","filing":"0000899243-21-011086","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924321011086/doc4.xml","form_type":"4"}},{"id":2797807,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":94911,"kind":"organization","name":"Braslyn Ltd.","position":1,"cik":"0001642355","reported_name":"Braslyn Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":2,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (right to purchase)","published_at":"2021-03-10T21:30:11.000Z","date":"2020-03-09","kind":"exercise","acquired":false,"shares":11971,"price":5.599,"value":67025.629,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The warrants do not have an expiration date and are not exercisable to the extent that, following exercise of such warrants, the warrant holder and its affiliates would beneficially own more than 19.99% of the issuer's common stock."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Tese securities are owned directly by Braslyn Ltd (\"Braslyn\"), which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Braslyn, (ii) Boxer Capital, LLC, (iii) Boxer Asset Management Inc., (iv) MVA Investors, LLC, (v) Lockend Five, LLC, (vi) Joe Lewis, (vii) Ivan M. Lieberburg, (viii) Aaron I. Davis, (ix) Shehan B. Dissanayake, and (x) Christopher Fuglesang (collectively, the \"Boxer Group). Each of Messrs. Fuglesang, Lieberburg, Dissanayake and Davis is a member of Boxer Capital. Each member of the Boxer Group other than Braslyn disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein."}],"balance_after":3578450,"derivative":{"exercise_price":0.001,"exercise_date":"2017-01-06","underlying":"Common Stock","underlying_shares":11971},"source":{"system":"sec-edgar","filing":"0000899243-21-011086","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924321011086/doc4.xml","form_type":"4"}},{"id":2797806,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":94911,"kind":"organization","name":"Braslyn Ltd.","position":1,"cik":"0001642355","reported_name":"Braslyn Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":2,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-03-10T21:30:11.000Z","date":"2021-03-10","kind":"sale","acquired":false,"shares":1,"price":195.9,"value":195.9,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Tese securities are owned directly by Braslyn Ltd (\"Braslyn\"), which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Braslyn, (ii) Boxer Capital, LLC, (iii) Boxer Asset Management Inc., (iv) MVA Investors, LLC, (v) Lockend Five, LLC, (vi) Joe Lewis, (vii) Ivan M. Lieberburg, (viii) Aaron I. Davis, (ix) Shehan B. Dissanayake, and (x) Christopher Fuglesang (collectively, the \"Boxer Group). Each of Messrs. Fuglesang, Lieberburg, Dissanayake and Davis is a member of Boxer Capital. Each member of the Boxer Group other than Braslyn disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein."}],"balance_after":3135966,"source":{"system":"sec-edgar","filing":"0000899243-21-011086","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924321011086/doc4.xml","form_type":"4"}},{"id":2797805,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":94911,"kind":"organization","name":"Braslyn Ltd.","position":1,"cik":"0001642355","reported_name":"Braslyn Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":2,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-03-10T21:30:11.000Z","date":"2021-03-10","kind":"exercise","acquired":true,"shares":410,"price":0.001,"value":0.41,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Tese securities are owned directly by Braslyn Ltd (\"Braslyn\"), which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Braslyn, (ii) Boxer Capital, LLC, (iii) Boxer Asset Management Inc., (iv) MVA Investors, LLC, (v) Lockend Five, LLC, (vi) Joe Lewis, (vii) Ivan M. Lieberburg, (viii) Aaron I. Davis, (ix) Shehan B. Dissanayake, and (x) Christopher Fuglesang (collectively, the \"Boxer Group). Each of Messrs. Fuglesang, Lieberburg, Dissanayake and Davis is a member of Boxer Capital. Each member of the Boxer Group other than Braslyn disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein."}],"balance_after":3135967,"source":{"system":"sec-edgar","filing":"0000899243-21-011086","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924321011086/doc4.xml","form_type":"4"}},{"id":2797804,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":94911,"kind":"organization","name":"Braslyn Ltd.","position":1,"cik":"0001642355","reported_name":"Braslyn Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":2,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-03-10T21:30:11.000Z","date":"2021-03-10","kind":"sale","acquired":false,"shares":200,"price":198,"value":39600.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Tese securities are owned directly by Braslyn Ltd (\"Braslyn\"), which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Braslyn, (ii) Boxer Capital, LLC, (iii) Boxer Asset Management Inc., (iv) MVA Investors, LLC, (v) Lockend Five, LLC, (vi) Joe Lewis, (vii) Ivan M. Lieberburg, (viii) Aaron I. Davis, (ix) Shehan B. Dissanayake, and (x) Christopher Fuglesang (collectively, the \"Boxer Group). Each of Messrs. Fuglesang, Lieberburg, Dissanayake and Davis is a member of Boxer Capital. Each member of the Boxer Group other than Braslyn disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein."}],"balance_after":3135557,"source":{"system":"sec-edgar","filing":"0000899243-21-011086","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924321011086/doc4.xml","form_type":"4"}},{"id":2797803,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":94911,"kind":"organization","name":"Braslyn Ltd.","position":1,"cik":"0001642355","reported_name":"Braslyn Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":2,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-03-10T21:30:11.000Z","date":"2021-03-10","kind":"sale","acquired":false,"shares":20,"price":196.12,"value":3922.4,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Tese securities are owned directly by Braslyn Ltd (\"Braslyn\"), which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Braslyn, (ii) Boxer Capital, LLC, (iii) Boxer Asset Management Inc., (iv) MVA Investors, LLC, (v) Lockend Five, LLC, (vi) Joe Lewis, (vii) Ivan M. Lieberburg, (viii) Aaron I. Davis, (ix) Shehan B. Dissanayake, and (x) Christopher Fuglesang (collectively, the \"Boxer Group). Each of Messrs. Fuglesang, Lieberburg, Dissanayake and Davis is a member of Boxer Capital. Each member of the Boxer Group other than Braslyn disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein."}],"balance_after":3135757,"source":{"system":"sec-edgar","filing":"0000899243-21-011086","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924321011086/doc4.xml","form_type":"4"}},{"id":2797802,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":94911,"kind":"organization","name":"Braslyn Ltd.","position":1,"cik":"0001642355","reported_name":"Braslyn Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":2,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-03-10T21:30:11.000Z","date":"2021-03-10","kind":"sale","acquired":false,"shares":189,"price":195.52,"value":36953.28,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Reflects the weighted average sale price. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $195.11 to $196.09."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Tese securities are owned directly by Braslyn Ltd (\"Braslyn\"), which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Braslyn, (ii) Boxer Capital, LLC, (iii) Boxer Asset Management Inc., (iv) MVA Investors, LLC, (v) Lockend Five, LLC, (vi) Joe Lewis, (vii) Ivan M. Lieberburg, (viii) Aaron I. Davis, (ix) Shehan B. Dissanayake, and (x) Christopher Fuglesang (collectively, the \"Boxer Group). Each of Messrs. Fuglesang, Lieberburg, Dissanayake and Davis is a member of Boxer Capital. Each member of the Boxer Group other than Braslyn disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein."}],"balance_after":3135777,"source":{"system":"sec-edgar","filing":"0000899243-21-011086","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924321011086/doc4.xml","form_type":"4"}},{"id":2797801,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":94911,"kind":"organization","name":"Braslyn Ltd.","position":1,"cik":"0001642355","reported_name":"Braslyn Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":2,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-03-10T21:30:11.000Z","date":"2021-03-09","kind":"sale","acquired":false,"shares":1,"price":191,"value":191.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Tese securities are owned directly by Braslyn Ltd (\"Braslyn\"), which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Braslyn, (ii) Boxer Capital, LLC, (iii) Boxer Asset Management Inc., (iv) MVA Investors, LLC, (v) Lockend Five, LLC, (vi) Joe Lewis, (vii) Ivan M. Lieberburg, (viii) Aaron I. Davis, (ix) Shehan B. Dissanayake, and (x) Christopher Fuglesang (collectively, the \"Boxer Group). Each of Messrs. Fuglesang, Lieberburg, Dissanayake and Davis is a member of Boxer Capital. Each member of the Boxer Group other than Braslyn disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein."}],"balance_after":3135966,"source":{"system":"sec-edgar","filing":"0000899243-21-011086","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924321011086/doc4.xml","form_type":"4"}},{"id":2797800,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":94911,"kind":"organization","name":"Braslyn Ltd.","position":1,"cik":"0001642355","reported_name":"Braslyn Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":2,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-03-10T21:30:11.000Z","date":"2021-03-09","kind":"exercise","acquired":true,"shares":11971,"price":0.001,"value":11.971,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Tese securities are owned directly by Braslyn Ltd (\"Braslyn\"), which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Braslyn, (ii) Boxer Capital, LLC, (iii) Boxer Asset Management Inc., (iv) MVA Investors, LLC, (v) Lockend Five, LLC, (vi) Joe Lewis, (vii) Ivan M. Lieberburg, (viii) Aaron I. Davis, (ix) Shehan B. Dissanayake, and (x) Christopher Fuglesang (collectively, the \"Boxer Group). Each of Messrs. Fuglesang, Lieberburg, Dissanayake and Davis is a member of Boxer Capital. Each member of the Boxer Group other than Braslyn disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein."}],"balance_after":3135967,"source":{"system":"sec-edgar","filing":"0000899243-21-011086","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924321011086/doc4.xml","form_type":"4"}},{"id":2797799,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":94911,"kind":"organization","name":"Braslyn Ltd.","position":1,"cik":"0001642355","reported_name":"Braslyn Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":2,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-03-10T21:30:11.000Z","date":"2021-03-09","kind":"sale","acquired":false,"shares":2237,"price":199.08,"value":445341.96,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Reflects the weighted average sale price. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $198.62 to $199.46."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Tese securities are owned directly by Braslyn Ltd (\"Braslyn\"), which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Braslyn, (ii) Boxer Capital, LLC, (iii) Boxer Asset Management Inc., (iv) MVA Investors, LLC, (v) Lockend Five, LLC, (vi) Joe Lewis, (vii) Ivan M. Lieberburg, (viii) Aaron I. Davis, (ix) Shehan B. Dissanayake, and (x) Christopher Fuglesang (collectively, the \"Boxer Group). Each of Messrs. Fuglesang, Lieberburg, Dissanayake and Davis is a member of Boxer Capital. Each member of the Boxer Group other than Braslyn disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein."}],"balance_after":3123996,"source":{"system":"sec-edgar","filing":"0000899243-21-011086","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924321011086/doc4.xml","form_type":"4"}},{"id":2797798,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":94911,"kind":"organization","name":"Braslyn Ltd.","position":1,"cik":"0001642355","reported_name":"Braslyn Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":2,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-03-10T21:30:11.000Z","date":"2021-03-09","kind":"sale","acquired":false,"shares":3993,"price":197.81,"value":789855.33,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Reflects the weighted average sale price. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $197.56 to $198.23."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Tese securities are owned directly by Braslyn Ltd (\"Braslyn\"), which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Braslyn, (ii) Boxer Capital, LLC, (iii) Boxer Asset Management Inc., (iv) MVA Investors, LLC, (v) Lockend Five, LLC, (vi) Joe Lewis, (vii) Ivan M. Lieberburg, (viii) Aaron I. Davis, (ix) Shehan B. Dissanayake, and (x) Christopher Fuglesang (collectively, the \"Boxer Group). Each of Messrs. Fuglesang, Lieberburg, Dissanayake and Davis is a member of Boxer Capital. Each member of the Boxer Group other than Braslyn disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein."}],"balance_after":3126233,"source":{"system":"sec-edgar","filing":"0000899243-21-011086","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924321011086/doc4.xml","form_type":"4"}},{"id":2797797,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":94911,"kind":"organization","name":"Braslyn Ltd.","position":1,"cik":"0001642355","reported_name":"Braslyn Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":2,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-03-10T21:30:11.000Z","date":"2021-03-09","kind":"sale","acquired":false,"shares":4633,"price":197.3,"value":914090.9,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects the weighted average sale price. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $196.55 to $197.53."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Tese securities are owned directly by Braslyn Ltd (\"Braslyn\"), which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Braslyn, (ii) Boxer Capital, LLC, (iii) Boxer Asset Management Inc., (iv) MVA Investors, LLC, (v) Lockend Five, LLC, (vi) Joe Lewis, (vii) Ivan M. Lieberburg, (viii) Aaron I. Davis, (ix) Shehan B. Dissanayake, and (x) Christopher Fuglesang (collectively, the \"Boxer Group). Each of Messrs. Fuglesang, Lieberburg, Dissanayake and Davis is a member of Boxer Capital. Each member of the Boxer Group other than Braslyn disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein."}],"balance_after":3130226,"source":{"system":"sec-edgar","filing":"0000899243-21-011086","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924321011086/doc4.xml","form_type":"4"}},{"id":2797796,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":94911,"kind":"organization","name":"Braslyn Ltd.","position":1,"cik":"0001642355","reported_name":"Braslyn Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":2,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-03-10T21:30:11.000Z","date":"2021-03-09","kind":"sale","acquired":false,"shares":1107,"price":195.82,"value":216772.74,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average sale price. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $195.24 to $196.20."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Tese securities are owned directly by Braslyn Ltd (\"Braslyn\"), which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Braslyn, (ii) Boxer Capital, LLC, (iii) Boxer Asset Management Inc., (iv) MVA Investors, LLC, (v) Lockend Five, LLC, (vi) Joe Lewis, (vii) Ivan M. Lieberburg, (viii) Aaron I. Davis, (ix) Shehan B. Dissanayake, and (x) Christopher Fuglesang (collectively, the \"Boxer Group). Each of Messrs. Fuglesang, Lieberburg, Dissanayake and Davis is a member of Boxer Capital. Each member of the Boxer Group other than Braslyn disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein."}],"balance_after":3134859,"source":{"system":"sec-edgar","filing":"0000899243-21-011086","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924321011086/doc4.xml","form_type":"4"}},{"id":2943210,"issuer":{"id":7061,"kind":"organization","name":"INSEEGO CORP.","symbol":"INSG"},"owners":[{"id":94911,"kind":"organization","name":"Braslyn Ltd.","position":1,"cik":"0001642355","reported_name":"Braslyn Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-16T22:42:32.000Z","date":"2020-12-16","kind":"sale","acquired":false,"shares":293848,"price":14.3749,"value":4224035.6152,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Reflects the weighted average sale price. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $14.00 to $14.70."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are owned directly by Braslyn Ltd. (\"Braslyn\"), which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of Braslyn, Golden Harbor Ltd., Tavistock Financial, LLC and Joseph C. Lewis. Mr. Lewis is the sole indirect beneficial owner of and controls Braslyn."}],"balance_after":7614830,"source":{"system":"sec-edgar","filing":"0000899243-20-034137","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1022652/000089924320034137/doc4.xml","form_type":"4"}},{"id":2943209,"issuer":{"id":7061,"kind":"organization","name":"INSEEGO CORP.","symbol":"INSG"},"owners":[{"id":94911,"kind":"organization","name":"Braslyn Ltd.","position":1,"cik":"0001642355","reported_name":"Braslyn Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-16T22:42:32.000Z","date":"2020-12-15","kind":"sale","acquired":false,"shares":190590,"price":14.8077,"value":2822199.543,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Reflects the weighted average sale price. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $14.50 to $15.20."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are owned directly by Braslyn Ltd. (\"Braslyn\"), which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of Braslyn, Golden Harbor Ltd., Tavistock Financial, LLC and Joseph C. Lewis. Mr. Lewis is the sole indirect beneficial owner of and controls Braslyn."}],"balance_after":7908678,"source":{"system":"sec-edgar","filing":"0000899243-20-034137","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1022652/000089924320034137/doc4.xml","form_type":"4"}},{"id":2943208,"issuer":{"id":7061,"kind":"organization","name":"INSEEGO CORP.","symbol":"INSG"},"owners":[{"id":94911,"kind":"organization","name":"Braslyn Ltd.","position":1,"cik":"0001642355","reported_name":"Braslyn Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-16T22:42:32.000Z","date":"2020-12-14","kind":"sale","acquired":false,"shares":178949,"price":16.07,"value":2875710.43,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects the weighted average sale price. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $16.01 to $16.38."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are owned directly by Braslyn Ltd. (\"Braslyn\"), which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of Braslyn, Golden Harbor Ltd., Tavistock Financial, LLC and Joseph C. Lewis. Mr. Lewis is the sole indirect beneficial owner of and controls Braslyn."}],"balance_after":8099268,"source":{"system":"sec-edgar","filing":"0000899243-20-034137","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1022652/000089924320034137/doc4.xml","form_type":"4"}},{"id":2943207,"issuer":{"id":7061,"kind":"organization","name":"INSEEGO CORP.","symbol":"INSG"},"owners":[{"id":94911,"kind":"organization","name":"Braslyn Ltd.","position":1,"cik":"0001642355","reported_name":"Braslyn Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-16T22:42:32.000Z","date":"2020-12-14","kind":"sale","acquired":false,"shares":1721783,"price":15.6185,"value":26891667.7855,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average sale price. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $15.01 to $16.005."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are owned directly by Braslyn Ltd. (\"Braslyn\"), which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of Braslyn, Golden Harbor Ltd., Tavistock Financial, LLC and Joseph C. Lewis. Mr. Lewis is the sole indirect beneficial owner of and controls Braslyn."}],"balance_after":8278217,"source":{"system":"sec-edgar","filing":"0000899243-20-034137","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1022652/000089924320034137/doc4.xml","form_type":"4"}},{"id":2997670,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":94911,"kind":"organization","name":"Braslyn Ltd.","position":1,"cik":"0001642355","reported_name":"Braslyn Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":2,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (right to purchase)","published_at":"2020-10-30T21:53:06.000Z","date":"2020-10-29","kind":"exercise","acquired":false,"shares":104565,"price":5.599,"value":585459.435,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F11","text":"The warrants do not have an expiration date and are not exercisable to the extent that, following exercise of such warrants, the warrant holder and its affiliates would beneficially own more than 19.99% of the issuer's common stock."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are owned directly by Braslyn Ltd (\"Braslyn\"), which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Braslyn, (ii) Boxer Capital, LLC (\"Boxer Capital\") (iii) Boxer Asset Management Inc. (\"Boxer Management\"), (iv) MVA Investors, LLC (\"MVA Investors\"), (v) Lockend Five, LLC (\"Lockend Five\"), (vi) Joe Lewis, (vii) Ivan M. Lieberburg, (viii) Aaron I. Davis, (ix) Shehan B. Dissanayake, and (x) Christopher Fuglesang (collectively, the \"Boxer Group). Each of Messrs. Fuglesang, Lieberburg, Dissanayake and Davis is a member of Boxer Capital. Each member of the Boxer Group other than Braslyn disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein."}],"balance_after":3590421,"derivative":{"exercise_price":0.001,"exercise_date":"2017-01-06","underlying":"Common Stock","underlying_shares":104565},"source":{"system":"sec-edgar","filing":"0000899243-20-030059","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":31,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924320030059/doc4.xml","form_type":"4"}},{"id":2997669,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":94911,"kind":"organization","name":"Braslyn Ltd.","position":1,"cik":"0001642355","reported_name":"Braslyn Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":2,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (right to purchase)","published_at":"2020-10-30T21:53:06.000Z","date":"2020-10-28","kind":"exercise","acquired":false,"shares":295438,"price":5.599,"value":1654157.362,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F11","text":"The warrants do not have an expiration date and are not exercisable to the extent that, following exercise of such warrants, the warrant holder and its affiliates would beneficially own more than 19.99% of the issuer's common stock."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are owned directly by Braslyn Ltd (\"Braslyn\"), which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Braslyn, (ii) Boxer Capital, LLC (\"Boxer Capital\") (iii) Boxer Asset Management Inc. (\"Boxer Management\"), (iv) MVA Investors, LLC (\"MVA Investors\"), (v) Lockend Five, LLC (\"Lockend Five\"), (vi) Joe Lewis, (vii) Ivan M. Lieberburg, (viii) Aaron I. Davis, (ix) Shehan B. Dissanayake, and (x) Christopher Fuglesang (collectively, the \"Boxer Group). Each of Messrs. Fuglesang, Lieberburg, Dissanayake and Davis is a member of Boxer Capital. Each member of the Boxer Group other than Braslyn disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein."}],"balance_after":3694986,"derivative":{"exercise_price":0.001,"exercise_date":"2017-01-06","underlying":"Common Stock","underlying_shares":295438},"source":{"system":"sec-edgar","filing":"0000899243-20-030059","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":30,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924320030059/doc4.xml","form_type":"4"}},{"id":2997668,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":94911,"kind":"organization","name":"Braslyn Ltd.","position":1,"cik":"0001642355","reported_name":"Braslyn Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":2,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-10-30T21:53:06.000Z","date":"2020-10-29","kind":"tax_withholding","acquired":false,"shares":1,"price":202.25,"value":202.25,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are owned directly by Braslyn Ltd (\"Braslyn\"), which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Braslyn, (ii) Boxer Capital, LLC (\"Boxer Capital\") (iii) Boxer Asset Management Inc. (\"Boxer Management\"), (iv) MVA Investors, LLC (\"MVA Investors\"), (v) Lockend Five, LLC (\"Lockend Five\"), (vi) Joe Lewis, (vii) Ivan M. Lieberburg, (viii) Aaron I. Davis, (ix) Shehan B. Dissanayake, and (x) Christopher Fuglesang (collectively, the \"Boxer Group). Each of Messrs. Fuglesang, Lieberburg, Dissanayake and Davis is a member of Boxer Capital. Each member of the Boxer Group other than Braslyn disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein."}],"balance_after":3135966,"source":{"system":"sec-edgar","filing":"0000899243-20-030059","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":29,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924320030059/doc4.xml","form_type":"4"}},{"id":2997667,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":94911,"kind":"organization","name":"Braslyn Ltd.","position":1,"cik":"0001642355","reported_name":"Braslyn Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":2,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-10-30T21:53:06.000Z","date":"2020-10-29","kind":"exercise","acquired":true,"shares":104565,"price":0.001,"value":104.565,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are owned directly by Braslyn Ltd (\"Braslyn\"), which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Braslyn, (ii) Boxer Capital, LLC (\"Boxer Capital\") (iii) Boxer Asset Management Inc. (\"Boxer Management\"), (iv) MVA Investors, LLC (\"MVA Investors\"), (v) Lockend Five, LLC (\"Lockend Five\"), (vi) Joe Lewis, (vii) Ivan M. Lieberburg, (viii) Aaron I. Davis, (ix) Shehan B. Dissanayake, and (x) Christopher Fuglesang (collectively, the \"Boxer Group). Each of Messrs. Fuglesang, Lieberburg, Dissanayake and Davis is a member of Boxer Capital. Each member of the Boxer Group other than Braslyn disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein."}],"balance_after":3135967,"source":{"system":"sec-edgar","filing":"0000899243-20-030059","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":28,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924320030059/doc4.xml","form_type":"4"}},{"id":2997666,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":94911,"kind":"organization","name":"Braslyn Ltd.","position":1,"cik":"0001642355","reported_name":"Braslyn Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":2,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-10-30T21:53:06.000Z","date":"2020-10-29","kind":"sale","acquired":false,"shares":818,"price":220.024,"value":179979.632,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F27","text":"Reflects the weighted average sale price. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $220.00 to $220.17."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are owned directly by Braslyn Ltd (\"Braslyn\"), which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Braslyn, (ii) Boxer Capital, LLC (\"Boxer Capital\") (iii) Boxer Asset Management Inc. (\"Boxer Management\"), (iv) MVA Investors, LLC (\"MVA Investors\"), (v) Lockend Five, LLC (\"Lockend Five\"), (vi) Joe Lewis, (vii) Ivan M. Lieberburg, (viii) Aaron I. Davis, (ix) Shehan B. Dissanayake, and (x) Christopher Fuglesang (collectively, the \"Boxer Group). Each of Messrs. Fuglesang, Lieberburg, Dissanayake and Davis is a member of Boxer Capital. Each member of the Boxer Group other than Braslyn disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein."}],"balance_after":3031402,"source":{"system":"sec-edgar","filing":"0000899243-20-030059","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":27,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924320030059/doc4.xml","form_type":"4"}},{"id":2997665,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":94911,"kind":"organization","name":"Braslyn Ltd.","position":1,"cik":"0001642355","reported_name":"Braslyn Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":2,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-10-30T21:53:06.000Z","date":"2020-10-29","kind":"sale","acquired":false,"shares":663,"price":218.85,"value":145097.55,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F26","text":"Reflects the weighted average sale price. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $218.62 to $219.08."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are owned directly by Braslyn Ltd (\"Braslyn\"), which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Braslyn, (ii) Boxer Capital, LLC (\"Boxer Capital\") (iii) Boxer Asset Management Inc. (\"Boxer Management\"), (iv) MVA Investors, LLC (\"MVA Investors\"), (v) Lockend Five, LLC (\"Lockend Five\"), (vi) Joe Lewis, (vii) Ivan M. Lieberburg, (viii) Aaron I. Davis, (ix) Shehan B. Dissanayake, and (x) Christopher Fuglesang (collectively, the \"Boxer Group). Each of Messrs. Fuglesang, Lieberburg, Dissanayake and Davis is a member of Boxer Capital. Each member of the Boxer Group other than Braslyn disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein."}],"balance_after":3032220,"source":{"system":"sec-edgar","filing":"0000899243-20-030059","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":26,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924320030059/doc4.xml","form_type":"4"}},{"id":2997664,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":94911,"kind":"organization","name":"Braslyn Ltd.","position":1,"cik":"0001642355","reported_name":"Braslyn Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":2,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-10-30T21:53:06.000Z","date":"2020-10-29","kind":"sale","acquired":false,"shares":5912,"price":218.0354,"value":1289025.2848,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F25","text":"Reflects the weighted average sale price. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $217.63 to $218.59."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are owned directly by Braslyn Ltd (\"Braslyn\"), which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Braslyn, (ii) Boxer Capital, LLC (\"Boxer Capital\") (iii) Boxer Asset Management Inc. (\"Boxer Management\"), (iv) MVA Investors, LLC (\"MVA Investors\"), (v) Lockend Five, LLC (\"Lockend Five\"), (vi) Joe Lewis, (vii) Ivan M. Lieberburg, (viii) Aaron I. Davis, (ix) Shehan B. Dissanayake, and (x) Christopher Fuglesang (collectively, the \"Boxer Group). Each of Messrs. Fuglesang, Lieberburg, Dissanayake and Davis is a member of Boxer Capital. Each member of the Boxer Group other than Braslyn disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein."}],"balance_after":3032883,"source":{"system":"sec-edgar","filing":"0000899243-20-030059","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":25,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924320030059/doc4.xml","form_type":"4"}},{"id":2997663,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":94911,"kind":"organization","name":"Braslyn Ltd.","position":1,"cik":"0001642355","reported_name":"Braslyn Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":2,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-10-30T21:53:06.000Z","date":"2020-10-29","kind":"sale","acquired":false,"shares":6775,"price":217.1449,"value":1471156.6975,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F24","text":"Reflects the weighted average sale price. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $216.63 to $217.62."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are owned directly by Braslyn Ltd (\"Braslyn\"), which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Braslyn, (ii) Boxer Capital, LLC (\"Boxer Capital\") (iii) Boxer Asset Management Inc. (\"Boxer Management\"), (iv) MVA Investors, LLC (\"MVA Investors\"), (v) Lockend Five, LLC (\"Lockend Five\"), (vi) Joe Lewis, (vii) Ivan M. Lieberburg, (viii) Aaron I. Davis, (ix) Shehan B. Dissanayake, and (x) Christopher Fuglesang (collectively, the \"Boxer Group). Each of Messrs. Fuglesang, Lieberburg, Dissanayake and Davis is a member of Boxer Capital. Each member of the Boxer Group other than Braslyn disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein."}],"balance_after":3038795,"source":{"system":"sec-edgar","filing":"0000899243-20-030059","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":24,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924320030059/doc4.xml","form_type":"4"}},{"id":2997662,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":94911,"kind":"organization","name":"Braslyn Ltd.","position":1,"cik":"0001642355","reported_name":"Braslyn Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":2,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-10-30T21:53:06.000Z","date":"2020-10-29","kind":"sale","acquired":false,"shares":11656,"price":216.0551,"value":2518338.2456,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F23","text":"Reflects the weighted average sale price. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $215.62 to $216.61."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are owned directly by Braslyn Ltd (\"Braslyn\"), which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Braslyn, (ii) Boxer Capital, LLC (\"Boxer Capital\") (iii) Boxer Asset Management Inc. (\"Boxer Management\"), (iv) MVA Investors, LLC (\"MVA Investors\"), (v) Lockend Five, LLC (\"Lockend Five\"), (vi) Joe Lewis, (vii) Ivan M. Lieberburg, (viii) Aaron I. Davis, (ix) Shehan B. Dissanayake, and (x) Christopher Fuglesang (collectively, the \"Boxer Group). Each of Messrs. Fuglesang, Lieberburg, Dissanayake and Davis is a member of Boxer Capital. Each member of the Boxer Group other than Braslyn disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein."}],"balance_after":3045570,"source":{"system":"sec-edgar","filing":"0000899243-20-030059","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":23,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924320030059/doc4.xml","form_type":"4"}},{"id":2997661,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":94911,"kind":"organization","name":"Braslyn Ltd.","position":1,"cik":"0001642355","reported_name":"Braslyn Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":2,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-10-30T21:53:06.000Z","date":"2020-10-29","kind":"sale","acquired":false,"shares":27992,"price":215.0756,"value":6020396.1952,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F22","text":"Reflects the weighted average sale price. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $214.61 to $215.605."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are owned directly by Braslyn Ltd (\"Braslyn\"), which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Braslyn, (ii) Boxer Capital, LLC (\"Boxer Capital\") (iii) Boxer Asset Management Inc. (\"Boxer Management\"), (iv) MVA Investors, LLC (\"MVA Investors\"), (v) Lockend Five, LLC (\"Lockend Five\"), (vi) Joe Lewis, (vii) Ivan M. Lieberburg, (viii) Aaron I. Davis, (ix) Shehan B. Dissanayake, and (x) Christopher Fuglesang (collectively, the \"Boxer Group). Each of Messrs. Fuglesang, Lieberburg, Dissanayake and Davis is a member of Boxer Capital. Each member of the Boxer Group other than Braslyn disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein."}],"balance_after":3057226,"source":{"system":"sec-edgar","filing":"0000899243-20-030059","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":22,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924320030059/doc4.xml","form_type":"4"}},{"id":2997660,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":94911,"kind":"organization","name":"Braslyn Ltd.","position":1,"cik":"0001642355","reported_name":"Braslyn Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":2,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-10-30T21:53:06.000Z","date":"2020-10-29","kind":"sale","acquired":false,"shares":2344,"price":214.3069,"value":502335.3736,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F21","text":"Reflects the weighted average sale price. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $213.61 to $214.57."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are owned directly by Braslyn Ltd (\"Braslyn\"), which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Braslyn, (ii) Boxer Capital, LLC (\"Boxer Capital\") (iii) Boxer Asset Management Inc. (\"Boxer Management\"), (iv) MVA Investors, LLC (\"MVA Investors\"), (v) Lockend Five, LLC (\"Lockend Five\"), (vi) Joe Lewis, (vii) Ivan M. Lieberburg, (viii) Aaron I. Davis, (ix) Shehan B. Dissanayake, and (x) Christopher Fuglesang (collectively, the \"Boxer Group). Each of Messrs. Fuglesang, Lieberburg, Dissanayake and Davis is a member of Boxer Capital. Each member of the Boxer Group other than Braslyn disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein."}],"balance_after":3085218,"source":{"system":"sec-edgar","filing":"0000899243-20-030059","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":21,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924320030059/doc4.xml","form_type":"4"}},{"id":2997659,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":94911,"kind":"organization","name":"Braslyn Ltd.","position":1,"cik":"0001642355","reported_name":"Braslyn Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":2,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-10-30T21:53:06.000Z","date":"2020-10-29","kind":"sale","acquired":false,"shares":3108,"price":212.6598,"value":660946.6584,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F20","text":"Reflects the weighted average sale price. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $212.13 to $212.98."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are owned directly by Braslyn Ltd (\"Braslyn\"), which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Braslyn, (ii) Boxer Capital, LLC (\"Boxer Capital\") (iii) Boxer Asset Management Inc. (\"Boxer Management\"), (iv) MVA Investors, LLC (\"MVA Investors\"), (v) Lockend Five, LLC (\"Lockend Five\"), (vi) Joe Lewis, (vii) Ivan M. Lieberburg, (viii) Aaron I. Davis, (ix) Shehan B. Dissanayake, and (x) Christopher Fuglesang (collectively, the \"Boxer Group). Each of Messrs. Fuglesang, Lieberburg, Dissanayake and Davis is a member of Boxer Capital. Each member of the Boxer Group other than Braslyn disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein."}],"balance_after":3087562,"source":{"system":"sec-edgar","filing":"0000899243-20-030059","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924320030059/doc4.xml","form_type":"4"}},{"id":2997658,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":94911,"kind":"organization","name":"Braslyn Ltd.","position":1,"cik":"0001642355","reported_name":"Braslyn Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":2,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-10-30T21:53:06.000Z","date":"2020-10-29","kind":"sale","acquired":false,"shares":14408,"price":211.5033,"value":3047339.5464,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F19","text":"Reflects the weighted average sale price. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $211.07 to $212.045."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are owned directly by Braslyn Ltd (\"Braslyn\"), which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Braslyn, (ii) Boxer Capital, LLC (\"Boxer Capital\") (iii) Boxer Asset Management Inc. (\"Boxer Management\"), (iv) MVA Investors, LLC (\"MVA Investors\"), (v) Lockend Five, LLC (\"Lockend Five\"), (vi) Joe Lewis, (vii) Ivan M. Lieberburg, (viii) Aaron I. Davis, (ix) Shehan B. Dissanayake, and (x) Christopher Fuglesang (collectively, the \"Boxer Group). Each of Messrs. Fuglesang, Lieberburg, Dissanayake and Davis is a member of Boxer Capital. Each member of the Boxer Group other than Braslyn disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein."}],"balance_after":3090670,"source":{"system":"sec-edgar","filing":"0000899243-20-030059","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924320030059/doc4.xml","form_type":"4"}},{"id":2997657,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":94911,"kind":"organization","name":"Braslyn Ltd.","position":1,"cik":"0001642355","reported_name":"Braslyn Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":2,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-10-30T21:53:06.000Z","date":"2020-10-29","kind":"sale","acquired":false,"shares":10599,"price":210.5807,"value":2231944.8393,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F18","text":"Reflects the weighted average sale price. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $210.06 to $211.03."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are owned directly by Braslyn Ltd (\"Braslyn\"), which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Braslyn, (ii) Boxer Capital, LLC (\"Boxer Capital\") (iii) Boxer Asset Management Inc. (\"Boxer Management\"), (iv) MVA Investors, LLC (\"MVA Investors\"), (v) Lockend Five, LLC (\"Lockend Five\"), (vi) Joe Lewis, (vii) Ivan M. Lieberburg, (viii) Aaron I. Davis, (ix) Shehan B. Dissanayake, and (x) Christopher Fuglesang (collectively, the \"Boxer Group). Each of Messrs. Fuglesang, Lieberburg, Dissanayake and Davis is a member of Boxer Capital. Each member of the Boxer Group other than Braslyn disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein."}],"balance_after":3105078,"source":{"system":"sec-edgar","filing":"0000899243-20-030059","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924320030059/doc4.xml","form_type":"4"}},{"id":2997656,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":94911,"kind":"organization","name":"Braslyn Ltd.","position":1,"cik":"0001642355","reported_name":"Braslyn Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":2,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-10-30T21:53:06.000Z","date":"2020-10-29","kind":"sale","acquired":false,"shares":15091,"price":209.6594,"value":3163970.0054,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F17","text":"Reflects the weighted average sale price. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $209.05 to $210.04."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are owned directly by Braslyn Ltd (\"Braslyn\"), which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Braslyn, (ii) Boxer Capital, LLC (\"Boxer Capital\") (iii) Boxer Asset Management Inc. (\"Boxer Management\"), (iv) MVA Investors, LLC (\"MVA Investors\"), (v) Lockend Five, LLC (\"Lockend Five\"), (vi) Joe Lewis, (vii) Ivan M. Lieberburg, (viii) Aaron I. Davis, (ix) Shehan B. Dissanayake, and (x) Christopher Fuglesang (collectively, the \"Boxer Group). Each of Messrs. Fuglesang, Lieberburg, Dissanayake and Davis is a member of Boxer Capital. Each member of the Boxer Group other than Braslyn disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein."}],"balance_after":3115677,"source":{"system":"sec-edgar","filing":"0000899243-20-030059","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924320030059/doc4.xml","form_type":"4"}},{"id":2997655,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":94911,"kind":"organization","name":"Braslyn Ltd.","position":1,"cik":"0001642355","reported_name":"Braslyn Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":2,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-10-30T21:53:06.000Z","date":"2020-10-29","kind":"sale","acquired":false,"shares":1674,"price":208.7801,"value":349497.8874,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F16","text":"Reflects the weighted average sale price. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $208.50 to $209.04."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are owned directly by Braslyn Ltd (\"Braslyn\"), which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Braslyn, (ii) Boxer Capital, LLC (\"Boxer Capital\") (iii) Boxer Asset Management Inc. (\"Boxer Management\"), (iv) MVA Investors, LLC (\"MVA Investors\"), (v) Lockend Five, LLC (\"Lockend Five\"), (vi) Joe Lewis, (vii) Ivan M. Lieberburg, (viii) Aaron I. Davis, (ix) Shehan B. Dissanayake, and (x) Christopher Fuglesang (collectively, the \"Boxer Group). Each of Messrs. Fuglesang, Lieberburg, Dissanayake and Davis is a member of Boxer Capital. Each member of the Boxer Group other than Braslyn disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein."}],"balance_after":3130768,"source":{"system":"sec-edgar","filing":"0000899243-20-030059","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924320030059/doc4.xml","form_type":"4"}},{"id":2997654,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":94911,"kind":"organization","name":"Braslyn Ltd.","position":1,"cik":"0001642355","reported_name":"Braslyn Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":2,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-10-30T21:53:06.000Z","date":"2020-10-29","kind":"sale","acquired":false,"shares":1086,"price":207.9643,"value":225849.2298,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F15","text":"Reflects the weighted average sale price. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $207.475 to $208.32."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are owned directly by Braslyn Ltd (\"Braslyn\"), which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Braslyn, (ii) Boxer Capital, LLC (\"Boxer Capital\") (iii) Boxer Asset Management Inc. (\"Boxer Management\"), (iv) MVA Investors, LLC (\"MVA Investors\"), (v) Lockend Five, LLC (\"Lockend Five\"), (vi) Joe Lewis, (vii) Ivan M. Lieberburg, (viii) Aaron I. Davis, (ix) Shehan B. Dissanayake, and (x) Christopher Fuglesang (collectively, the \"Boxer Group). Each of Messrs. Fuglesang, Lieberburg, Dissanayake and Davis is a member of Boxer Capital. Each member of the Boxer Group other than Braslyn disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein."}],"balance_after":3132442,"source":{"system":"sec-edgar","filing":"0000899243-20-030059","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924320030059/doc4.xml","form_type":"4"}},{"id":2997653,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":94911,"kind":"organization","name":"Braslyn Ltd.","position":1,"cik":"0001642355","reported_name":"Braslyn Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":2,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-10-30T21:53:06.000Z","date":"2020-10-29","kind":"sale","acquired":false,"shares":1088,"price":206.499,"value":224670.912,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F14","text":"Reflects the weighted average sale price. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $206.12 to $207.03."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are owned directly by Braslyn Ltd (\"Braslyn\"), which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Braslyn, (ii) Boxer Capital, LLC (\"Boxer Capital\") (iii) Boxer Asset Management Inc. (\"Boxer Management\"), (iv) MVA Investors, LLC (\"MVA Investors\"), (v) Lockend Five, LLC (\"Lockend Five\"), (vi) Joe Lewis, (vii) Ivan M. Lieberburg, (viii) Aaron I. Davis, (ix) Shehan B. Dissanayake, and (x) Christopher Fuglesang (collectively, the \"Boxer Group). Each of Messrs. Fuglesang, Lieberburg, Dissanayake and Davis is a member of Boxer Capital. Each member of the Boxer Group other than Braslyn disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein."}],"balance_after":3133528,"source":{"system":"sec-edgar","filing":"0000899243-20-030059","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924320030059/doc4.xml","form_type":"4"}},{"id":2997652,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":94911,"kind":"organization","name":"Braslyn Ltd.","position":1,"cik":"0001642355","reported_name":"Braslyn Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":2,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-10-30T21:53:06.000Z","date":"2020-10-29","kind":"sale","acquired":false,"shares":800,"price":205.6448,"value":164515.84,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F13","text":"Reflects the weighted average sale price. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $205.12 to $206.00."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are owned directly by Braslyn Ltd (\"Braslyn\"), which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Braslyn, (ii) Boxer Capital, LLC (\"Boxer Capital\") (iii) Boxer Asset Management Inc. (\"Boxer Management\"), (iv) MVA Investors, LLC (\"MVA Investors\"), (v) Lockend Five, LLC (\"Lockend Five\"), (vi) Joe Lewis, (vii) Ivan M. Lieberburg, (viii) Aaron I. Davis, (ix) Shehan B. Dissanayake, and (x) Christopher Fuglesang (collectively, the \"Boxer Group). Each of Messrs. Fuglesang, Lieberburg, Dissanayake and Davis is a member of Boxer Capital. Each member of the Boxer Group other than Braslyn disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein."}],"balance_after":3134616,"source":{"system":"sec-edgar","filing":"0000899243-20-030059","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924320030059/doc4.xml","form_type":"4"}},{"id":2997651,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":94911,"kind":"organization","name":"Braslyn Ltd.","position":1,"cik":"0001642355","reported_name":"Braslyn Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":2,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-10-30T21:53:06.000Z","date":"2020-10-29","kind":"sale","acquired":false,"shares":550,"price":203.3228,"value":111827.54,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F12","text":"Reflects the weighted average sale price. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $203.03 to $203.69."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are owned directly by Braslyn Ltd (\"Braslyn\"), which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Braslyn, (ii) Boxer Capital, LLC (\"Boxer Capital\") (iii) Boxer Asset Management Inc. (\"Boxer Management\"), (iv) MVA Investors, LLC (\"MVA Investors\"), (v) Lockend Five, LLC (\"Lockend Five\"), (vi) Joe Lewis, (vii) Ivan M. Lieberburg, (viii) Aaron I. Davis, (ix) Shehan B. Dissanayake, and (x) Christopher Fuglesang (collectively, the \"Boxer Group). Each of Messrs. Fuglesang, Lieberburg, Dissanayake and Davis is a member of Boxer Capital. Each member of the Boxer Group other than Braslyn disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein."}],"balance_after":3135416,"source":{"system":"sec-edgar","filing":"0000899243-20-030059","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924320030059/doc4.xml","form_type":"4"}},{"id":2997650,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":94911,"kind":"organization","name":"Braslyn Ltd.","position":1,"cik":"0001642355","reported_name":"Braslyn Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":2,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-10-30T21:53:06.000Z","date":"2020-10-28","kind":"tax_withholding","acquired":false,"shares":2,"price":209.16,"value":418.32,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are owned directly by Braslyn Ltd (\"Braslyn\"), which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Braslyn, (ii) Boxer Capital, LLC (\"Boxer Capital\") (iii) Boxer Asset Management Inc. (\"Boxer Management\"), (iv) MVA Investors, LLC (\"MVA Investors\"), (v) Lockend Five, LLC (\"Lockend Five\"), (vi) Joe Lewis, (vii) Ivan M. Lieberburg, (viii) Aaron I. Davis, (ix) Shehan B. Dissanayake, and (x) Christopher Fuglesang (collectively, the \"Boxer Group). Each of Messrs. Fuglesang, Lieberburg, Dissanayake and Davis is a member of Boxer Capital. Each member of the Boxer Group other than Braslyn disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein."}],"balance_after":3135966,"source":{"system":"sec-edgar","filing":"0000899243-20-030059","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924320030059/doc4.xml","form_type":"4"}},{"id":2997649,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":94911,"kind":"organization","name":"Braslyn Ltd.","position":1,"cik":"0001642355","reported_name":"Braslyn Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":2,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-10-30T21:53:06.000Z","date":"2020-10-28","kind":"exercise","acquired":true,"shares":295438,"price":0.001,"value":295.438,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are owned directly by Braslyn Ltd (\"Braslyn\"), which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Braslyn, (ii) Boxer Capital, LLC (\"Boxer Capital\") (iii) Boxer Asset Management Inc. (\"Boxer Management\"), (iv) MVA Investors, LLC (\"MVA Investors\"), (v) Lockend Five, LLC (\"Lockend Five\"), (vi) Joe Lewis, (vii) Ivan M. Lieberburg, (viii) Aaron I. Davis, (ix) Shehan B. Dissanayake, and (x) Christopher Fuglesang (collectively, the \"Boxer Group). Each of Messrs. Fuglesang, Lieberburg, Dissanayake and Davis is a member of Boxer Capital. Each member of the Boxer Group other than Braslyn disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein."}],"balance_after":3135968,"source":{"system":"sec-edgar","filing":"0000899243-20-030059","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924320030059/doc4.xml","form_type":"4"}},{"id":2997648,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":94911,"kind":"organization","name":"Braslyn Ltd.","position":1,"cik":"0001642355","reported_name":"Braslyn Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":2,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-10-30T21:53:06.000Z","date":"2020-10-28","kind":"sale","acquired":false,"shares":500,"price":211.063,"value":105531.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F10","text":"Reflects the weighted average sale price. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $211.06 to $211.065."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are owned directly by Braslyn Ltd (\"Braslyn\"), which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Braslyn, (ii) Boxer Capital, LLC (\"Boxer Capital\") (iii) Boxer Asset Management Inc. (\"Boxer Management\"), (iv) MVA Investors, LLC (\"MVA Investors\"), (v) Lockend Five, LLC (\"Lockend Five\"), (vi) Joe Lewis, (vii) Ivan M. Lieberburg, (viii) Aaron I. Davis, (ix) Shehan B. Dissanayake, and (x) Christopher Fuglesang (collectively, the \"Boxer Group). Each of Messrs. Fuglesang, Lieberburg, Dissanayake and Davis is a member of Boxer Capital. Each member of the Boxer Group other than Braslyn disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein."}],"balance_after":2840530,"source":{"system":"sec-edgar","filing":"0000899243-20-030059","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924320030059/doc4.xml","form_type":"4"}},{"id":2997647,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":94911,"kind":"organization","name":"Braslyn Ltd.","position":1,"cik":"0001642355","reported_name":"Braslyn Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":2,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-10-30T21:53:06.000Z","date":"2020-10-28","kind":"sale","acquired":false,"shares":23283,"price":210.31,"value":4896647.73,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Reflects the weighted average sale price. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $210.00 to $210.99."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are owned directly by Braslyn Ltd (\"Braslyn\"), which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Braslyn, (ii) Boxer Capital, LLC (\"Boxer Capital\") (iii) Boxer Asset Management Inc. (\"Boxer Management\"), (iv) MVA Investors, LLC (\"MVA Investors\"), (v) Lockend Five, LLC (\"Lockend Five\"), (vi) Joe Lewis, (vii) Ivan M. Lieberburg, (viii) Aaron I. Davis, (ix) Shehan B. Dissanayake, and (x) Christopher Fuglesang (collectively, the \"Boxer Group). Each of Messrs. Fuglesang, Lieberburg, Dissanayake and Davis is a member of Boxer Capital. Each member of the Boxer Group other than Braslyn disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein."}],"balance_after":2841030,"source":{"system":"sec-edgar","filing":"0000899243-20-030059","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924320030059/doc4.xml","form_type":"4"}},{"id":2997646,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":94911,"kind":"organization","name":"Braslyn Ltd.","position":1,"cik":"0001642355","reported_name":"Braslyn Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":2,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-10-30T21:53:06.000Z","date":"2020-10-28","kind":"sale","acquired":false,"shares":37428,"price":209.47,"value":7840043.16,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Reflects the weighted average sale price. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $209.00 to $209.99."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are owned directly by Braslyn Ltd (\"Braslyn\"), which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Braslyn, (ii) Boxer Capital, LLC (\"Boxer Capital\") (iii) Boxer Asset Management Inc. (\"Boxer Management\"), (iv) MVA Investors, LLC (\"MVA Investors\"), (v) Lockend Five, LLC (\"Lockend Five\"), (vi) Joe Lewis, (vii) Ivan M. Lieberburg, (viii) Aaron I. Davis, (ix) Shehan B. Dissanayake, and (x) Christopher Fuglesang (collectively, the \"Boxer Group). Each of Messrs. Fuglesang, Lieberburg, Dissanayake and Davis is a member of Boxer Capital. Each member of the Boxer Group other than Braslyn disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein."}],"balance_after":2864313,"source":{"system":"sec-edgar","filing":"0000899243-20-030059","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924320030059/doc4.xml","form_type":"4"}},{"id":2997645,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":94911,"kind":"organization","name":"Braslyn Ltd.","position":1,"cik":"0001642355","reported_name":"Braslyn Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":2,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-10-30T21:53:06.000Z","date":"2020-10-28","kind":"sale","acquired":false,"shares":25036,"price":208.4,"value":5217502.4,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Reflects the weighted average sale price. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $208.00 to $208.995."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are owned directly by Braslyn Ltd (\"Braslyn\"), which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Braslyn, (ii) Boxer Capital, LLC (\"Boxer Capital\") (iii) Boxer Asset Management Inc. (\"Boxer Management\"), (iv) MVA Investors, LLC (\"MVA Investors\"), (v) Lockend Five, LLC (\"Lockend Five\"), (vi) Joe Lewis, (vii) Ivan M. Lieberburg, (viii) Aaron I. Davis, (ix) Shehan B. Dissanayake, and (x) Christopher Fuglesang (collectively, the \"Boxer Group). Each of Messrs. Fuglesang, Lieberburg, Dissanayake and Davis is a member of Boxer Capital. Each member of the Boxer Group other than Braslyn disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein."}],"balance_after":2901741,"source":{"system":"sec-edgar","filing":"0000899243-20-030059","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924320030059/doc4.xml","form_type":"4"}},{"id":2997644,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":94911,"kind":"organization","name":"Braslyn Ltd.","position":1,"cik":"0001642355","reported_name":"Braslyn Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":2,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-10-30T21:53:06.000Z","date":"2020-10-28","kind":"sale","acquired":false,"shares":38525,"price":207.35,"value":7988158.75,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Reflects the weighted average sale price. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $207.00 to $207.99."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are owned directly by Braslyn Ltd (\"Braslyn\"), which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Braslyn, (ii) Boxer Capital, LLC (\"Boxer Capital\") (iii) Boxer Asset Management Inc. (\"Boxer Management\"), (iv) MVA Investors, LLC (\"MVA Investors\"), (v) Lockend Five, LLC (\"Lockend Five\"), (vi) Joe Lewis, (vii) Ivan M. Lieberburg, (viii) Aaron I. Davis, (ix) Shehan B. Dissanayake, and (x) Christopher Fuglesang (collectively, the \"Boxer Group). Each of Messrs. Fuglesang, Lieberburg, Dissanayake and Davis is a member of Boxer Capital. Each member of the Boxer Group other than Braslyn disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein."}],"balance_after":2926777,"source":{"system":"sec-edgar","filing":"0000899243-20-030059","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924320030059/doc4.xml","form_type":"4"}},{"id":2997643,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":94911,"kind":"organization","name":"Braslyn Ltd.","position":1,"cik":"0001642355","reported_name":"Braslyn Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":2,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-10-30T21:53:06.000Z","date":"2020-10-28","kind":"sale","acquired":false,"shares":41266,"price":206.5,"value":8521429.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Reflects the weighted average sale price. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $206.00 to $206.99."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are owned directly by Braslyn Ltd (\"Braslyn\"), which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Braslyn, (ii) Boxer Capital, LLC (\"Boxer Capital\") (iii) Boxer Asset Management Inc. (\"Boxer Management\"), (iv) MVA Investors, LLC (\"MVA Investors\"), (v) Lockend Five, LLC (\"Lockend Five\"), (vi) Joe Lewis, (vii) Ivan M. Lieberburg, (viii) Aaron I. Davis, (ix) Shehan B. Dissanayake, and (x) Christopher Fuglesang (collectively, the \"Boxer Group). Each of Messrs. Fuglesang, Lieberburg, Dissanayake and Davis is a member of Boxer Capital. Each member of the Boxer Group other than Braslyn disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein."}],"balance_after":2965302,"source":{"system":"sec-edgar","filing":"0000899243-20-030059","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924320030059/doc4.xml","form_type":"4"}},{"id":2997642,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":94911,"kind":"organization","name":"Braslyn Ltd.","position":1,"cik":"0001642355","reported_name":"Braslyn Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":2,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-10-30T21:53:06.000Z","date":"2020-10-28","kind":"sale","acquired":false,"shares":45896,"price":205.49,"value":9431169.04,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Reflects the weighted average sale price. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $205.00 to $205.99."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are owned directly by Braslyn Ltd (\"Braslyn\"), which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Braslyn, (ii) Boxer Capital, LLC (\"Boxer Capital\") (iii) Boxer Asset Management Inc. (\"Boxer Management\"), (iv) MVA Investors, LLC (\"MVA Investors\"), (v) Lockend Five, LLC (\"Lockend Five\"), (vi) Joe Lewis, (vii) Ivan M. Lieberburg, (viii) Aaron I. Davis, (ix) Shehan B. Dissanayake, and (x) Christopher Fuglesang (collectively, the \"Boxer Group). Each of Messrs. Fuglesang, Lieberburg, Dissanayake and Davis is a member of Boxer Capital. Each member of the Boxer Group other than Braslyn disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein."}],"balance_after":3006568,"source":{"system":"sec-edgar","filing":"0000899243-20-030059","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924320030059/doc4.xml","form_type":"4"}},{"id":2997641,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":94911,"kind":"organization","name":"Braslyn Ltd.","position":1,"cik":"0001642355","reported_name":"Braslyn Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":2,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-10-30T21:53:06.000Z","date":"2020-10-28","kind":"sale","acquired":false,"shares":38543,"price":204.57,"value":7884741.51,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects the weighted average sale price. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $204.00 to $204.99."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are owned directly by Braslyn Ltd (\"Braslyn\"), which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Braslyn, (ii) Boxer Capital, LLC (\"Boxer Capital\") (iii) Boxer Asset Management Inc. (\"Boxer Management\"), (iv) MVA Investors, LLC (\"MVA Investors\"), (v) Lockend Five, LLC (\"Lockend Five\"), (vi) Joe Lewis, (vii) Ivan M. Lieberburg, (viii) Aaron I. Davis, (ix) Shehan B. Dissanayake, and (x) Christopher Fuglesang (collectively, the \"Boxer Group). Each of Messrs. Fuglesang, Lieberburg, Dissanayake and Davis is a member of Boxer Capital. Each member of the Boxer Group other than Braslyn disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein."}],"balance_after":3052464,"source":{"system":"sec-edgar","filing":"0000899243-20-030059","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924320030059/doc4.xml","form_type":"4"}},{"id":2997640,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":94911,"kind":"organization","name":"Braslyn Ltd.","position":1,"cik":"0001642355","reported_name":"Braslyn Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":2,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-10-30T21:53:06.000Z","date":"2020-10-28","kind":"sale","acquired":false,"shares":44959,"price":203.348,"value":9142322.732,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Reflects the weighted average sale price. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $203.00 to $203.98."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are owned directly by Braslyn Ltd (\"Braslyn\"), which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Braslyn, (ii) Boxer Capital, LLC (\"Boxer Capital\") (iii) Boxer Asset Management Inc. (\"Boxer Management\"), (iv) MVA Investors, LLC (\"MVA Investors\"), (v) Lockend Five, LLC (\"Lockend Five\"), (vi) Joe Lewis, (vii) Ivan M. Lieberburg, (viii) Aaron I. Davis, (ix) Shehan B. Dissanayake, and (x) Christopher Fuglesang (collectively, the \"Boxer Group). Each of Messrs. Fuglesang, Lieberburg, Dissanayake and Davis is a member of Boxer Capital. Each member of the Boxer Group other than Braslyn disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein."}],"balance_after":3091007,"source":{"system":"sec-edgar","filing":"0000899243-20-030059","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924320030059/doc4.xml","form_type":"4"}},{"id":3079152,"issuer":{"id":11788,"kind":"organization","name":"Pandion Therapeutics, Inc.","symbol":"PAND"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":94911,"kind":"organization","name":"Braslyn Ltd.","position":3,"cik":"0001642355","reported_name":"Braslyn Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":4,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":6,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2020-07-21T19:49:15.000Z","date":"2020-07-21","kind":"exercise","acquired":false,"shares":120460,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series B Preferred Stock converted into Common Stock on a 5.0994-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series B Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series B Preferred Stock converted into Common Stock on a 5.0994-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series B Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series B Preferred Stock converted into Common Stock on a 5.0994-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series B Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are owned directly and solely by MVA Investors, which has sole voting and dispositive power with respect to these securities. Each member of the Boxer Group other than MVA Investors disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":23622},"source":{"system":"sec-edgar","filing":"0000899243-20-019894","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924320019894/doc4.xml","form_type":"4"}},{"id":3079151,"issuer":{"id":11788,"kind":"organization","name":"Pandion Therapeutics, Inc.","symbol":"PAND"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":94911,"kind":"organization","name":"Braslyn Ltd.","position":3,"cik":"0001642355","reported_name":"Braslyn Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":4,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":6,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2020-07-21T19:49:15.000Z","date":"2020-07-21","kind":"exercise","acquired":false,"shares":7064136,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series B Preferred Stock converted into Common Stock on a 5.0994-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series B Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series B Preferred Stock converted into Common Stock on a 5.0994-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series B Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series B Preferred Stock converted into Common Stock on a 5.0994-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series B Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These securities are owned directly by Boxer Capital, LLC (\"Boxer Capital\"), which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Boxer Capital, (ii) Boxer Asset Management Inc. (\"Boxer Management\"), (iii) Braslyn Ltd. (\"Braslyn\"), (iv) Joseph C. Lewis, (v) MVA Investors, LLC (\"MVA Investors\") and (vi) Aaron I. Davis (collectively, the \"Boxer Group\"), and indirectly by Boxer Management and Joseph C. Lewis by virtue of their ownership in Boxer Capital. Each member of the Boxer Group other than Boxer Capital disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1385291},"source":{"system":"sec-edgar","filing":"0000899243-20-019894","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924320019894/doc4.xml","form_type":"4"}},{"id":3079150,"issuer":{"id":11788,"kind":"organization","name":"Pandion Therapeutics, Inc.","symbol":"PAND"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":94911,"kind":"organization","name":"Braslyn Ltd.","position":3,"cik":"0001642355","reported_name":"Braslyn Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":4,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":6,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-07-21T19:49:15.000Z","date":"2020-07-21","kind":"purchase","acquired":true,"shares":722222,"price":18,"value":12999996.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These securities are owned directly by Boxer Capital, LLC (\"Boxer Capital\"), which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Boxer Capital, (ii) Boxer Asset Management Inc. (\"Boxer Management\"), (iii) Braslyn Ltd. (\"Braslyn\"), (iv) Joseph C. Lewis, (v) MVA Investors, LLC (\"MVA Investors\") and (vi) Aaron I. Davis (collectively, the \"Boxer Group\"), and indirectly by Boxer Management and Joseph C. Lewis by virtue of their ownership in Boxer Capital. Each member of the Boxer Group other than Boxer Capital disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein."}],"balance_after":2107513,"source":{"system":"sec-edgar","filing":"0000899243-20-019894","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924320019894/doc4.xml","form_type":"4"}},{"id":3079149,"issuer":{"id":11788,"kind":"organization","name":"Pandion Therapeutics, Inc.","symbol":"PAND"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":94911,"kind":"organization","name":"Braslyn Ltd.","position":3,"cik":"0001642355","reported_name":"Braslyn Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":4,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":6,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-07-21T19:49:15.000Z","date":"2020-07-21","kind":"exercise","acquired":true,"shares":23622,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Series B Preferred Stock converted into Common Stock on a 5.0994-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series B Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These securities are owned directly and solely by MVA Investors, which has sole voting and dispositive power with respect to these securities. Each member of the Boxer Group other than MVA Investors disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein."}],"balance_after":23622,"source":{"system":"sec-edgar","filing":"0000899243-20-019894","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924320019894/doc4.xml","form_type":"4"}},{"id":3079148,"issuer":{"id":11788,"kind":"organization","name":"Pandion Therapeutics, Inc.","symbol":"PAND"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":91094,"kind":"organization","name":"Boxer Asset Management Inc.","position":2,"cik":"0001465836","reported_name":"Boxer Asset Management Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":94911,"kind":"organization","name":"Braslyn Ltd.","position":3,"cik":"0001642355","reported_name":"Braslyn Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":4,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":5,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":6,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-07-21T19:49:15.000Z","date":"2020-07-21","kind":"exercise","acquired":true,"shares":1385291,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Series B Preferred Stock converted into Common Stock on a 5.0994-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series B Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These securities are owned directly by Boxer Capital, LLC (\"Boxer Capital\"), which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Boxer Capital, (ii) Boxer Asset Management Inc. (\"Boxer Management\"), (iii) Braslyn Ltd. (\"Braslyn\"), (iv) Joseph C. Lewis, (v) MVA Investors, LLC (\"MVA Investors\") and (vi) Aaron I. Davis (collectively, the \"Boxer Group\"), and indirectly by Boxer Management and Joseph C. Lewis by virtue of their ownership in Boxer Capital. Each member of the Boxer Group other than Boxer Capital disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein."}],"balance_after":1385291,"source":{"system":"sec-edgar","filing":"0000899243-20-019894","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924320019894/doc4.xml","form_type":"4"}},{"id":3108397,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":94911,"kind":"organization","name":"Braslyn Ltd.","position":1,"cik":"0001642355","reported_name":"Braslyn Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (right to purchase)","published_at":"2020-06-16T19:09:01.000Z","date":"2020-06-12","kind":"exercise","acquired":false,"shares":600006,"price":5.599,"value":3359433.594,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The warrants do not have an expiration date and are not exercisable to the extent that, following exercise of such warrants, the warrant holder and its affiliates would beneficially own more than 9.99% of the issuer's common stock."}],"balance_after":3990420,"derivative":{"exercise_price":0.001,"exercise_date":"2017-01-06","underlying":"Common Stock","underlying_shares":600006},"source":{"system":"sec-edgar","filing":"0000899243-20-016700","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1576263/000089924320016700/doc4a.xml","form_type":"4/A","original_submission_date":"2020-06-16"}},{"id":3108396,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":94911,"kind":"organization","name":"Braslyn Ltd.","position":1,"cik":"0001642355","reported_name":"Braslyn Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-06-16T19:09:01.000Z","date":"2020-06-12","kind":"tax_withholding","acquired":false,"shares":6,"price":100.69,"value":604.14,"ownership":{"direct":true},"balance_after":3135966,"source":{"system":"sec-edgar","filing":"0000899243-20-016700","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1576263/000089924320016700/doc4a.xml","form_type":"4/A","original_submission_date":"2020-06-16"}},{"id":3108395,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":94911,"kind":"organization","name":"Braslyn Ltd.","position":1,"cik":"0001642355","reported_name":"Braslyn Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-06-16T19:09:01.000Z","date":"2020-06-12","kind":"exercise","acquired":true,"shares":600006,"price":0.001,"value":600.006,"ownership":{"direct":true},"balance_after":3135972,"source":{"system":"sec-edgar","filing":"0000899243-20-016700","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1576263/000089924320016700/doc4a.xml","form_type":"4/A","original_submission_date":"2020-06-16"}},{"id":3108394,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":94911,"kind":"organization","name":"Braslyn Ltd.","position":1,"cik":"0001642355","reported_name":"Braslyn Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-06-16T19:09:01.000Z","date":"2020-06-12","kind":"sale","acquired":false,"shares":600000,"price":97,"value":58200000.0,"ownership":{"direct":true},"balance_after":2535966,"source":{"system":"sec-edgar","filing":"0000899243-20-016700","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1576263/000089924320016700/doc4a.xml","form_type":"4/A","original_submission_date":"2020-06-16"}},{"id":3108393,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":94911,"kind":"organization","name":"Braslyn Ltd.","position":1,"cik":"0001642355","reported_name":"Braslyn Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (right to purchase)","published_at":"2020-06-16T17:03:33.000Z","date":"2020-06-12","kind":"exercise","acquired":false,"shares":600006,"price":5.599,"value":3359433.594,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The warrants do not have an expiration date and are not exercisable to the extent that, following exercise of such warrants, the warrant holder and its affiliates would beneficially own more than 9.99% of the issuer's common stock."}],"balance_after":3990420,"derivative":{"exercise_price":0.001,"exercise_date":"2017-01-06","underlying":"Common Stock","underlying_shares":600006},"source":{"system":"sec-edgar","filing":"0000899243-20-016664","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1576263/000089924320016664/doc4.xml","form_type":"4"}},{"id":3108392,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":94911,"kind":"organization","name":"Braslyn Ltd.","position":1,"cik":"0001642355","reported_name":"Braslyn Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-06-16T17:03:33.000Z","date":"2020-06-12","kind":"tax_withholding","acquired":false,"shares":6,"price":72.8,"value":436.8,"ownership":{"direct":true},"balance_after":3135966,"source":{"system":"sec-edgar","filing":"0000899243-20-016664","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1576263/000089924320016664/doc4.xml","form_type":"4"}},{"id":3108391,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":94911,"kind":"organization","name":"Braslyn Ltd.","position":1,"cik":"0001642355","reported_name":"Braslyn Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-06-16T17:03:33.000Z","date":"2020-06-12","kind":"exercise","acquired":true,"shares":600006,"price":0.001,"value":600.006,"ownership":{"direct":true},"balance_after":3135972,"source":{"system":"sec-edgar","filing":"0000899243-20-016664","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1576263/000089924320016664/doc4.xml","form_type":"4"}},{"id":3108390,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":94911,"kind":"organization","name":"Braslyn Ltd.","position":1,"cik":"0001642355","reported_name":"Braslyn Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-06-16T17:03:33.000Z","date":"2020-06-12","kind":"sale","acquired":false,"shares":600000,"price":69,"value":41400000.0,"ownership":{"direct":true},"balance_after":2535966,"source":{"system":"sec-edgar","filing":"0000899243-20-016664","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1576263/000089924320016664/doc4.xml","form_type":"4"}},{"id":3610623,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":94911,"kind":"organization","name":"Braslyn Ltd.","position":1,"cik":"0001642355","reported_name":"Braslyn Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (right to purchase)","published_at":"2019-03-05T21:30:38.000Z","date":"2019-03-01","kind":"exercise","acquired":false,"shares":275004,"price":5.599,"value":1539747.396,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The warrants do not have an expiration date and are not exercisable to the extent that, following exercise of such warrants, the warrant holder and its affiliates would beneficially own more than 19.99% of the issuer's common stock."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are owned directly by Braslyn Ltd. (\"Braslyn\") which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Braslyn, (ii) Boxer Capital, LLC, (iii) Boxer Asset Management Inc., (iv) MVA Investors, LLC, (v) Joe Lewis, (vi) Rodney W. Lappe, (vii) Ivan M. Lieberburg, (viii) Aaron I. Davis, (ix) Neil Reisman, (x) Shehan B. Dissanayake, and (xi) Christopher Fuglesang (collectively, the \"Boxer Group). Joe Lewis is the sole indirect beneficial owner of and controls Braslyn."}],"balance_after":4590426,"derivative":{"exercise_price":0.001,"exercise_date":"2017-01-06","underlying":"Common Stock","underlying_shares":275004},"source":{"system":"sec-edgar","filing":"0000899243-19-006351","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1576263/000089924319006351/doc4.xml","form_type":"4"}},{"id":3610622,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":94911,"kind":"organization","name":"Braslyn Ltd.","position":1,"cik":"0001642355","reported_name":"Braslyn Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-03-05T21:30:38.000Z","date":"2019-03-01","kind":"tax_withholding","acquired":false,"shares":4,"price":72.8,"value":291.2,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are owned directly by Braslyn Ltd. (\"Braslyn\") which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Braslyn, (ii) Boxer Capital, LLC, (iii) Boxer Asset Management Inc., (iv) MVA Investors, LLC, (v) Joe Lewis, (vi) Rodney W. Lappe, (vii) Ivan M. Lieberburg, (viii) Aaron I. Davis, (ix) Neil Reisman, (x) Shehan B. Dissanayake, and (xi) Christopher Fuglesang (collectively, the \"Boxer Group). Joe Lewis is the sole indirect beneficial owner of and controls Braslyn."}],"balance_after":3135966,"source":{"system":"sec-edgar","filing":"0000899243-19-006351","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1576263/000089924319006351/doc4.xml","form_type":"4"}},{"id":3610621,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":94911,"kind":"organization","name":"Braslyn Ltd.","position":1,"cik":"0001642355","reported_name":"Braslyn Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-03-05T21:30:38.000Z","date":"2019-03-01","kind":"exercise","acquired":true,"shares":275004,"price":0.001,"value":275.004,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are owned directly by Braslyn Ltd. (\"Braslyn\") which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Braslyn, (ii) Boxer Capital, LLC, (iii) Boxer Asset Management Inc., (iv) MVA Investors, LLC, (v) Joe Lewis, (vi) Rodney W. Lappe, (vii) Ivan M. Lieberburg, (viii) Aaron I. Davis, (ix) Neil Reisman, (x) Shehan B. Dissanayake, and (xi) Christopher Fuglesang (collectively, the \"Boxer Group). Joe Lewis is the sole indirect beneficial owner of and controls Braslyn."}],"balance_after":3135970,"source":{"system":"sec-edgar","filing":"0000899243-19-006351","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1576263/000089924319006351/doc4.xml","form_type":"4"}},{"id":3610620,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":94911,"kind":"organization","name":"Braslyn Ltd.","position":1,"cik":"0001642355","reported_name":"Braslyn Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-03-05T21:30:38.000Z","date":"2019-03-01","kind":"sale","acquired":false,"shares":275000,"price":69,"value":18975000.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are owned directly by Braslyn Ltd. (\"Braslyn\") which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Braslyn, (ii) Boxer Capital, LLC, (iii) Boxer Asset Management Inc., (iv) MVA Investors, LLC, (v) Joe Lewis, (vi) Rodney W. Lappe, (vii) Ivan M. Lieberburg, (viii) Aaron I. Davis, (ix) Neil Reisman, (x) Shehan B. Dissanayake, and (xi) Christopher Fuglesang (collectively, the \"Boxer Group). Joe Lewis is the sole indirect beneficial owner of and controls Braslyn."}],"balance_after":2860966,"source":{"system":"sec-edgar","filing":"0000899243-19-006351","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1576263/000089924319006351/doc4.xml","form_type":"4"}},{"id":4156307,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":94911,"kind":"organization","name":"Braslyn Ltd.","position":2,"cik":"0001642355","reported_name":"Braslyn Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (right to purchase)","published_at":"2017-11-20T16:55:18.000Z","date":"2017-11-16","kind":"purchase","acquired":true,"shares":1413475,"price":12.999,"value":18373761.525,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The warrants do not have an expiration date and are not exercisable to the extent that, following exercise of such warrants, the warrant holder and its affiliates would beneficially own more than 19.99% of the issuer's common stock."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These securities are owned directly by Braslyn, which may be deemed to be a member of the Boxer Group. Joe Lewis is the sole indirect beneficial owner of and controls Braslyn."}],"balance_after":1413475,"derivative":{"exercise_price":0.001,"exercise_date":"2017-11-16","underlying":"Common Stock","underlying_shares":1413475},"source":{"system":"sec-edgar","filing":"0000899243-17-026986","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1465837/000089924317026986/doc4.xml","form_type":"4"}},{"id":4156306,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":94911,"kind":"organization","name":"Braslyn Ltd.","position":2,"cik":"0001642355","reported_name":"Braslyn Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (right to purchase)","published_at":"2017-11-20T16:55:18.000Z","date":"2017-11-16","kind":"purchase","acquired":true,"shares":801448,"price":12.999,"value":10418022.552,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The warrants do not have an expiration date and are not exercisable to the extent that, following exercise of such warrants, the warrant holder and its affiliates would beneficially own more than 19.99% of the issuer's common stock."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are owned directly by Boxer Capital, LLC (\"Boxer Capital\"), which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Braslyn Ltd. (\"Braslyn\"), (ii) Boxer Capital, (iii) Boxer Asset Management Inc. (\"Boxer Management\"), (v) MVA Investors, LLC (\"MVA Investors\"), (vi) Joseph C. Lewis, (vii)  Rodney W. Lappe, (viii) Ivan M. Lieberburg, (ix) Aaron I. Davis, (x) Neil Reisman, (xi) Shehan B. Dissanayake, and (xii) Christopher Fuglesang (collectively, the \"Boxer Group), and indirectly by Boxer Management and Messrs. Lewis, Fuglesang, Reisman, Lieberburg, Dissanayake, and Davis, by virtue of their ownership in Boxer Capital. Each of Messrs. Fuglesang, Reisman, Lieberburg, Dissanayake and Davis is a member of Boxer Capital.  Each member of the Boxer Group other than Boxer Capital disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interes"}],"balance_after":801448,"derivative":{"exercise_price":0.001,"exercise_date":"2017-11-16","underlying":"Common Stock","underlying_shares":801448},"source":{"system":"sec-edgar","filing":"0000899243-17-026986","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1465837/000089924317026986/doc4.xml","form_type":"4"}},{"id":4156305,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":94911,"kind":"organization","name":"Braslyn Ltd.","position":2,"cik":"0001642355","reported_name":"Braslyn Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-11-20T16:55:18.000Z","date":"2017-11-16","kind":"purchase","acquired":true,"shares":255264,"price":13,"value":3318432.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These securities are owned directly by Braslyn, which may be deemed to be a member of the Boxer Group. Joe Lewis is the sole indirect beneficial owner of and controls Braslyn."}],"balance_after":3135966,"source":{"system":"sec-edgar","filing":"0000899243-17-026986","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1465837/000089924317026986/doc4.xml","form_type":"4"}},{"id":4156304,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":94911,"kind":"organization","name":"Braslyn Ltd.","position":2,"cik":"0001642355","reported_name":"Braslyn Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-11-20T16:55:18.000Z","date":"2017-11-16","kind":"purchase","acquired":true,"shares":144736,"price":13,"value":1881568.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are owned directly by Boxer Capital, LLC (\"Boxer Capital\"), which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Braslyn Ltd. (\"Braslyn\"), (ii) Boxer Capital, (iii) Boxer Asset Management Inc. (\"Boxer Management\"), (v) MVA Investors, LLC (\"MVA Investors\"), (vi) Joseph C. Lewis, (vii)  Rodney W. Lappe, (viii) Ivan M. Lieberburg, (ix) Aaron I. Davis, (x) Neil Reisman, (xi) Shehan B. Dissanayake, and (xii) Christopher Fuglesang (collectively, the \"Boxer Group), and indirectly by Boxer Management and Messrs. Lewis, Fuglesang, Reisman, Lieberburg, Dissanayake, and Davis, by virtue of their ownership in Boxer Capital. Each of Messrs. Fuglesang, Reisman, Lieberburg, Dissanayake and Davis is a member of Boxer Capital.  Each member of the Boxer Group other than Boxer Capital disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interes"}],"balance_after":1372510,"source":{"system":"sec-edgar","filing":"0000899243-17-026986","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1465837/000089924317026986/doc4.xml","form_type":"4"}},{"id":4195742,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":94911,"kind":"organization","name":"Braslyn Ltd.","position":2,"cik":"0001642355","reported_name":"Braslyn Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":94910,"kind":"person","name":"Fuglesang Christopher","position":4,"cik":"0001465835","reported_name":"Fuglesang Christopher","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39302,"kind":"person","name":"LAPPE RODNEY W","position":5,"cik":"0001579826","reported_name":"LAPPE RODNEY W","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":141647,"kind":"person","name":"LIEBERBURG IVAN M","position":6,"cik":"0001266427","reported_name":"LIEBERBURG IVAN M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":158472,"kind":"person","name":"Reisman Neil","position":7,"cik":"0001465834","reported_name":"Reisman Neil","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":94909,"kind":"person","name":"Dissanayake Shehan Bharatha","position":8,"cik":"0001663609","reported_name":"Dissanayake Shehan Bharatha","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":9,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":10,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (right to purchase)","published_at":"2017-10-03T18:21:42.000Z","date":"2017-10-03","kind":"other","acquired":false,"shares":78186,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":7.86,"exercise_date":"2012-11-21","expiration_date":"2017-11-21","underlying":"Common Stock","underlying_shares":78186},"source":{"system":"sec-edgar","filing":"0000899243-17-023345","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924317023345/doc4.xml","form_type":"4"}},{"id":4195741,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":94911,"kind":"organization","name":"Braslyn Ltd.","position":2,"cik":"0001642355","reported_name":"Braslyn Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":94910,"kind":"person","name":"Fuglesang Christopher","position":4,"cik":"0001465835","reported_name":"Fuglesang Christopher","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39302,"kind":"person","name":"LAPPE RODNEY W","position":5,"cik":"0001579826","reported_name":"LAPPE RODNEY W","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":141647,"kind":"person","name":"LIEBERBURG IVAN M","position":6,"cik":"0001266427","reported_name":"LIEBERBURG IVAN M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":158472,"kind":"person","name":"Reisman Neil","position":7,"cik":"0001465834","reported_name":"Reisman Neil","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":94909,"kind":"person","name":"Dissanayake Shehan Bharatha","position":8,"cik":"0001663609","reported_name":"Dissanayake Shehan Bharatha","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":9,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":10,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (right to purchase)","published_at":"2017-10-03T18:21:42.000Z","date":"2017-10-03","kind":"other","acquired":false,"shares":189780,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":7.86,"exercise_date":"2012-11-21","expiration_date":"2017-11-21","underlying":"Common Stock","underlying_shares":189780},"source":{"system":"sec-edgar","filing":"0000899243-17-023345","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924317023345/doc4.xml","form_type":"4"}},{"id":4195740,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":94911,"kind":"organization","name":"Braslyn Ltd.","position":2,"cik":"0001642355","reported_name":"Braslyn Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":94910,"kind":"person","name":"Fuglesang Christopher","position":4,"cik":"0001465835","reported_name":"Fuglesang Christopher","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39302,"kind":"person","name":"LAPPE RODNEY W","position":5,"cik":"0001579826","reported_name":"LAPPE RODNEY W","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":141647,"kind":"person","name":"LIEBERBURG IVAN M","position":6,"cik":"0001266427","reported_name":"LIEBERBURG IVAN M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":158472,"kind":"person","name":"Reisman Neil","position":7,"cik":"0001465834","reported_name":"Reisman Neil","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":94909,"kind":"person","name":"Dissanayake Shehan Bharatha","position":8,"cik":"0001663609","reported_name":"Dissanayake Shehan Bharatha","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":9,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":10,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-10-03T18:21:42.000Z","date":"2017-10-03","kind":"other","acquired":true,"shares":78186,"price":7.86,"value":614541.96,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These securities are owned directly and solely by MVA Investors, which has sole voting and dispositive power with respect to these securities. Each of Messrs. Fuglesang, Lieberburg, Reisman, Dissanayake and Davis is a member of MVA Investors. Each member of the Boxer Group other than MVA Investors disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein."}],"balance_after":513630,"source":{"system":"sec-edgar","filing":"0000899243-17-023345","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924317023345/doc4.xml","form_type":"4"}},{"id":4195739,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":91093,"kind":"organization","name":"Boxer Capital, LLC","position":1,"cik":"0001465837","reported_name":"Boxer Capital, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":94911,"kind":"organization","name":"Braslyn Ltd.","position":2,"cik":"0001642355","reported_name":"Braslyn Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":75394,"kind":"person","name":"LEWIS JOSEPH","position":3,"cik":"0001015747","reported_name":"LEWIS JOSEPH","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":94910,"kind":"person","name":"Fuglesang Christopher","position":4,"cik":"0001465835","reported_name":"Fuglesang Christopher","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":39302,"kind":"person","name":"LAPPE RODNEY W","position":5,"cik":"0001579826","reported_name":"LAPPE RODNEY W","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":141647,"kind":"person","name":"LIEBERBURG IVAN M","position":6,"cik":"0001266427","reported_name":"LIEBERBURG IVAN M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":158472,"kind":"person","name":"Reisman Neil","position":7,"cik":"0001465834","reported_name":"Reisman Neil","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":94909,"kind":"person","name":"Dissanayake Shehan Bharatha","position":8,"cik":"0001663609","reported_name":"Dissanayake Shehan Bharatha","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":86253,"kind":"person","name":"Davis Aaron I.","position":9,"cik":"0001465914","reported_name":"Davis Aaron I.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89263,"kind":"organization","name":"MVA Investors, LLC","position":10,"cik":"0001468223","reported_name":"MVA Investors, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-10-03T18:21:42.000Z","date":"2017-10-03","kind":"other","acquired":true,"shares":189780,"price":7.86,"value":1491670.8,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are owned directly by Boxer Capital, LLC (\"Boxer Capital\"), which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Boxer Capital, (ii) Boxer Asset Management Inc., (iii) MVA Investors, LLC (\"MVA Investors\"), (iv) Braslyn Ltd., (v) Joe Lewis, (vi) Christopher Fuglesang, (vii) Rodney W. Lappe, (viii) Ivan M. Lieberburg, (ix) Neil Reisman, (x) Shehan B. Dissanayake, and (xi) Aaron I. Davis (collectively, the \"Boxer Group\"). Joseph C. Lewis is the sole indirect beneficial owner of and controls Braslyn Ltd."}],"balance_after":1227774,"source":{"system":"sec-edgar","filing":"0000899243-17-023345","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1015747/000089924317023345/doc4.xml","form_type":"4"}},{"id":4476989,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":94911,"kind":"organization","name":"Braslyn Ltd.","position":1,"cik":"0001642355","reported_name":"Braslyn Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-01-30T17:00:42.000Z","date":"2017-01-26","kind":"purchase","acquired":true,"shares":28839,"price":5.45,"value":157172.55,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are owned directly by Braslyn Ltd. (\"Braslyn\") which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Braslyn, (ii) Boxer Capital, LLC, (iii) Boxer Asset Management Inc., (iv) MVA Investors, LLC, (v)  Joe Lewis, (vi)  Rodney W. Lappe, (vii) Ivan M. Lieberburg, (viii) Aaron I. Davis, (ix) Neil Reisman, (x) Shehan B. Dissanayake and (xi) Christopher Fuglesang. Joe Lewis is the sole indirect beneficial owner of and controls Braslyn."}],"balance_after":2880702,"source":{"system":"sec-edgar","filing":"0000899243-17-002188","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1576263/000089924317002188/doc4.xml","form_type":"4"}},{"id":4476988,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":94911,"kind":"organization","name":"Braslyn Ltd.","position":1,"cik":"0001642355","reported_name":"Braslyn Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-01-30T17:00:42.000Z","date":"2017-01-26","kind":"purchase","acquired":true,"shares":19330,"price":5.44,"value":105155.2,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are owned directly by Braslyn Ltd. (\"Braslyn\") which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Braslyn, (ii) Boxer Capital, LLC, (iii) Boxer Asset Management Inc., (iv) MVA Investors, LLC, (v)  Joe Lewis, (vi)  Rodney W. Lappe, (vii) Ivan M. Lieberburg, (viii) Aaron I. Davis, (ix) Neil Reisman, (x) Shehan B. Dissanayake and (xi) Christopher Fuglesang. Joe Lewis is the sole indirect beneficial owner of and controls Braslyn."}],"balance_after":2851863,"source":{"system":"sec-edgar","filing":"0000899243-17-002188","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1576263/000089924317002188/doc4.xml","form_type":"4"}},{"id":4481749,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":94911,"kind":"organization","name":"Braslyn Ltd.","position":1,"cik":"0001642355","reported_name":"Braslyn Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-01-25T17:00:22.000Z","date":"2017-01-25","kind":"purchase","acquired":true,"shares":30600,"price":5.42,"value":165852.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are owned directly by Braslyn Ltd. (\"Braslyn\") which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Braslyn, (ii) Boxer Capital, LLC, (iii) Boxer Asset Management Inc., (iv) MVA Investors, LLC, (v)  Joe Lewis, (vi)  Rodney W. Lappe, (vii) Ivan M. Lieberburg, (viii) Aaron I. Davis, (ix) Neil Reisman, (x) Shehan B. Dissanayake and (xi) Christopher Fuglesang. Joe Lewis is the sole indirect beneficial owner of and controls Braslyn."}],"balance_after":2832533,"source":{"system":"sec-edgar","filing":"0000899243-17-001947","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1576263/000089924317001947/doc4.xml","form_type":"4"}},{"id":4481748,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":94911,"kind":"organization","name":"Braslyn Ltd.","position":1,"cik":"0001642355","reported_name":"Braslyn Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-01-25T17:00:22.000Z","date":"2017-01-24","kind":"purchase","acquired":true,"shares":27682,"price":5.32,"value":147268.24,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are owned directly by Braslyn Ltd. (\"Braslyn\") which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Braslyn, (ii) Boxer Capital, LLC, (iii) Boxer Asset Management Inc., (iv) MVA Investors, LLC, (v)  Joe Lewis, (vi)  Rodney W. Lappe, (vii) Ivan M. Lieberburg, (viii) Aaron I. Davis, (ix) Neil Reisman, (x) Shehan B. Dissanayake and (xi) Christopher Fuglesang. Joe Lewis is the sole indirect beneficial owner of and controls Braslyn."}],"balance_after":2801933,"source":{"system":"sec-edgar","filing":"0000899243-17-001947","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1576263/000089924317001947/doc4.xml","form_type":"4"}},{"id":4481747,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":94911,"kind":"organization","name":"Braslyn Ltd.","position":1,"cik":"0001642355","reported_name":"Braslyn Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-01-25T17:00:22.000Z","date":"2017-01-23","kind":"purchase","acquired":true,"shares":19251,"price":5.27,"value":101452.77,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are owned directly by Braslyn Ltd. (\"Braslyn\") which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Braslyn, (ii) Boxer Capital, LLC, (iii) Boxer Asset Management Inc., (iv) MVA Investors, LLC, (v)  Joe Lewis, (vi)  Rodney W. Lappe, (vii) Ivan M. Lieberburg, (viii) Aaron I. Davis, (ix) Neil Reisman, (x) Shehan B. Dissanayake and (xi) Christopher Fuglesang. Joe Lewis is the sole indirect beneficial owner of and controls Braslyn."}],"balance_after":2774251,"source":{"system":"sec-edgar","filing":"0000899243-17-001947","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1576263/000089924317001947/doc4.xml","form_type":"4"}},{"id":4485100,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":94911,"kind":"organization","name":"Braslyn Ltd.","position":1,"cik":"0001642355","reported_name":"Braslyn Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-01-20T17:00:39.000Z","date":"2017-01-20","kind":"purchase","acquired":true,"shares":23873,"price":5.42,"value":129391.66,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are owned directly by Braslyn Ltd. (\"Braslyn\") which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Braslyn, (ii) Boxer Capital, LLC, (iii) Boxer Asset Management Inc., (iv) MVA Investors, LLC, (v)  Joe Lewis, (vi)  Rodney W. Lappe, (vii) Ivan M. Lieberburg, (viii) Aaron I. Davis, (ix) Neil Reisman, (x) Shehan B. Dissanayake and (xi) Christopher Fuglesang. Joe Lewis is the sole indirect beneficial owner of and controls Braslyn."}],"balance_after":2755000,"source":{"system":"sec-edgar","filing":"0000899243-17-001652","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1576263/000089924317001652/doc4.xml","form_type":"4"}},{"id":4485099,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":94911,"kind":"organization","name":"Braslyn Ltd.","position":1,"cik":"0001642355","reported_name":"Braslyn Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-01-20T17:00:39.000Z","date":"2017-01-19","kind":"purchase","acquired":true,"shares":21085,"price":5.48,"value":115545.8,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are owned directly by Braslyn Ltd. (\"Braslyn\") which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Braslyn, (ii) Boxer Capital, LLC, (iii) Boxer Asset Management Inc., (iv) MVA Investors, LLC, (v)  Joe Lewis, (vi)  Rodney W. Lappe, (vii) Ivan M. Lieberburg, (viii) Aaron I. Davis, (ix) Neil Reisman, (x) Shehan B. Dissanayake and (xi) Christopher Fuglesang. Joe Lewis is the sole indirect beneficial owner of and controls Braslyn."}],"balance_after":2731127,"source":{"system":"sec-edgar","filing":"0000899243-17-001652","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1576263/000089924317001652/doc4.xml","form_type":"4"}},{"id":4485098,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":94911,"kind":"organization","name":"Braslyn Ltd.","position":1,"cik":"0001642355","reported_name":"Braslyn Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-01-20T17:00:39.000Z","date":"2017-01-18","kind":"purchase","acquired":true,"shares":16200,"price":5.5,"value":89100.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are owned directly by Braslyn Ltd. (\"Braslyn\") which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Braslyn, (ii) Boxer Capital, LLC, (iii) Boxer Asset Management Inc., (iv) MVA Investors, LLC, (v)  Joe Lewis, (vi)  Rodney W. Lappe, (vii) Ivan M. Lieberburg, (viii) Aaron I. Davis, (ix) Neil Reisman, (x) Shehan B. Dissanayake and (xi) Christopher Fuglesang. Joe Lewis is the sole indirect beneficial owner of and controls Braslyn."}],"balance_after":2710042,"source":{"system":"sec-edgar","filing":"0000899243-17-001652","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1576263/000089924317001652/doc4.xml","form_type":"4"}},{"id":4489644,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":94911,"kind":"organization","name":"Braslyn Ltd.","position":1,"cik":"0001642355","reported_name":"Braslyn Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-01-17T17:00:47.000Z","date":"2017-01-17","kind":"purchase","acquired":true,"shares":17800,"price":5.5,"value":97900.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are owned directly by Braslyn Ltd. (\"Braslyn\") which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Braslyn, (ii) Boxer Capital, LLC, (iii) Boxer Asset Management Inc., (iv) MVA Investors, LLC, (v)  Joe Lewis, (vi)  Rodney W. Lappe, (vii) Ivan M. Lieberburg, (viii) Aaron I. Davis, (ix) Neil Reisman, (x) Shehan B. Dissanayake and (xi) Christopher Fuglesang. Joe Lewis is the sole indirect beneficial owner of and controls Braslyn."}],"balance_after":2693842,"source":{"system":"sec-edgar","filing":"0000899243-17-001335","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1576263/000089924317001335/doc4.xml","form_type":"4"}},{"id":4489643,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":94911,"kind":"organization","name":"Braslyn Ltd.","position":1,"cik":"0001642355","reported_name":"Braslyn Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-01-17T17:00:47.000Z","date":"2017-01-13","kind":"purchase","acquired":true,"shares":52311,"price":5.49,"value":287187.39,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are owned directly by Braslyn Ltd. (\"Braslyn\") which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Braslyn, (ii) Boxer Capital, LLC, (iii) Boxer Asset Management Inc., (iv) MVA Investors, LLC, (v)  Joe Lewis, (vi)  Rodney W. Lappe, (vii) Ivan M. Lieberburg, (viii) Aaron I. Davis, (ix) Neil Reisman, (x) Shehan B. Dissanayake and (xi) Christopher Fuglesang. Joe Lewis is the sole indirect beneficial owner of and controls Braslyn."}],"balance_after":2676042,"source":{"system":"sec-edgar","filing":"0000899243-17-001335","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1576263/000089924317001335/doc4.xml","form_type":"4"}},{"id":4489642,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":94911,"kind":"organization","name":"Braslyn Ltd.","position":1,"cik":"0001642355","reported_name":"Braslyn Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-01-17T17:00:47.000Z","date":"2017-01-12","kind":"purchase","acquired":true,"shares":49776,"price":5.5,"value":273768.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are owned directly by Braslyn Ltd. (\"Braslyn\") which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Braslyn, (ii) Boxer Capital, LLC, (iii) Boxer Asset Management Inc., (iv) MVA Investors, LLC, (v)  Joe Lewis, (vi)  Rodney W. Lappe, (vii) Ivan M. Lieberburg, (viii) Aaron I. Davis, (ix) Neil Reisman, (x) Shehan B. Dissanayake and (xi) Christopher Fuglesang. Joe Lewis is the sole indirect beneficial owner of and controls Braslyn."}],"balance_after":2623731,"source":{"system":"sec-edgar","filing":"0000899243-17-001335","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1576263/000089924317001335/doc4.xml","form_type":"4"}},{"id":4493774,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":94911,"kind":"organization","name":"Braslyn Ltd.","position":1,"cik":"0001642355","reported_name":"Braslyn Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (right to purchase)","published_at":"2017-01-10T17:00:44.000Z","date":"2017-01-06","kind":"purchase","acquired":true,"shares":4865430,"price":5.599,"value":27241542.57,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The warrants do not have an expiration date and are not exercisable to the extent that, following exercise of such warrants, the warrant holder and its affiliates would beneficially own more than 19.99% of the issuer's common stock."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are owned directly by Braslyn Ltd. (\"Braslyn\") which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Braslyn, (ii) Boxer Capital, LLC (\"Boxer Capital\"), (iii) Boxer Asset Management Inc. (\"Boxer Management\"), (v) MVA Investors, LLC (\"MVA Investors\"), (vi)  Joe Lewis, (vii)  Rodney W. Lappe, (viii) Ivan M. Lieberburg, (ix) Aaron I. Davis, (x) Neil Reisman, (xi) Shehan B. Dissanayake, and (xii) Christopher Fuglesang (collectively, the \"Boxer Group). Joe Lewis is the sole indirect beneficial owner of and controls Braslyn."}],"balance_after":4865430,"derivative":{"exercise_price":0.001,"exercise_date":"2017-01-06","underlying":"Common Stock","underlying_shares":4865430},"source":{"system":"sec-edgar","filing":"0000899243-17-000988","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1576263/000089924317000988/doc4.xml","form_type":"4"}},{"id":4493773,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":94911,"kind":"organization","name":"Braslyn Ltd.","position":1,"cik":"0001642355","reported_name":"Braslyn Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-01-10T17:00:44.000Z","date":"2017-01-06","kind":"purchase","acquired":true,"shares":581870,"price":5.6,"value":3258472.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are owned directly by Braslyn Ltd. (\"Braslyn\") which may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Braslyn, (ii) Boxer Capital, LLC (\"Boxer Capital\"), (iii) Boxer Asset Management Inc. (\"Boxer Management\"), (v) MVA Investors, LLC (\"MVA Investors\"), (vi)  Joe Lewis, (vii)  Rodney W. Lappe, (viii) Ivan M. Lieberburg, (ix) Aaron I. Davis, (x) Neil Reisman, (xi) Shehan B. Dissanayake, and (xii) Christopher Fuglesang (collectively, the \"Boxer Group). Joe Lewis is the sole indirect beneficial owner of and controls Braslyn."}],"balance_after":2573955,"source":{"system":"sec-edgar","filing":"0000899243-17-000988","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1576263/000089924317000988/doc4.xml","form_type":"4"}}]}